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Résumé
L’ oxygène est indispensable à la vie aérobique. Cependant, certains métabolites
de cette molécule peuvent devenir des espèces oxygénées activées (EOA), des radicaux
libres extrêmement réactifs pouvant causer des dommages à plusieurs composants
cellulaires tels que les lipides, les protéines et l’ADN. Les EOA sont une source de
stresse inévitable et permanent puisqu’elles sont générées par des processus endogènes;
ces molécules sont des sous-produits de la respiration cellulaire et sont générées par des
cellules immunitaires pour combattre l’infection de corps étrangers. De plus, ils sont
produits à la suite de l’exposition à plusieurs agents exogènes tels que certaines longueurs
d’onde émises par le soleil ainsi que de nombreux métaux et drogues. Par conséquent,
les cellules ont développés plusieurs mécanismes qui permettent d’empêcher ou de
réparer les dommages dus aux EOA. Notamment, la réparation par excision des bases est
la voie principale de réparation de l’ADN endommagé par ces radicaux libres, permettant
d’éviter à ce que les lésions oxydatives deviennent des mutations permanentes.
Cependant, si ces mécanismes sont altérés, les cellules peuvent devenir particulièrement
vu]nerables face aux dommages causés par les EOA. En effet, de nombreuses
pathologies sont associées au stress oxydatif, tels que certaines maladies
cardiovasculaires, neurodégénératives, le diabète et le cancer. Une meilleure
connaissance des gènes impliqués dans la réponse cellulaire face aux stresses oxydatifs
pourrait nous permettre de mieux comprendre ces maladies sur le plan biologique.
Lors d’un criblage de souches de levures mutantes, l’homologue du gène
Phosphotyrosyl Phosphatase Activator (PIPA) humain, RRD 1, à été identifié comme
jouant un rôle important dans le maintient de l’intégrité de l’ADN exposé aux EAO.
Quoique le mécanisme d’action et la fonction précise de PTPA ne soient pas bien
caractérisés, plusieurs évidences suggèrent que ce gène joue un rôle dans plusieurs
processus biologiques, dont certains étant liés à la carcinogenèse. Etant donné
l’importance du stresse oxydatif dans l’initiation de certains types de cancer et du rôle de
PTPA dans le maintien de l’intégrité l’ADN face à ce stresse, nous avons chercher à
étudier ce gène chez les mammifères en produisant de souris ayant soit une délétion, soit
une surexpression de la protéine Ptpa. Nous avons préparé la construction d’ADN en
vue de créer des souries knockout «conditionnelle» pour ce gène, et avons générer des
wcolonie de souris ayant intégré une copie supplémentaire du gène PIPA fusionné avec
une protéine dérivée de la protéine fluorescente verte sans, pour autant, exprimer le
transgene. Une fois que ces souris manipulées génétiquement seront établies, elles
pourront être exposées a divers sources de stresse oxydatif. Ceci permettrait l’étude du
fonctionnement de PIPA dans la réponse aux EOA.
Mots clés: PIPA, RRD1, stress oxydatif, UVA, dommages à l’ADN, souris
transgénique, souris knockout, cre-loxP, protéine verte fluorescente
VAbstract
Oxygen molecules are essential for aerobic life. However, certain free radical
metabolites of oxygen molecules, Reactive Oxygen Species (ROS), can cause significant
damage to cellular lipids, proteins and DNA. ROS are a constant threat to celiular
integrity as they are produced by endogenous processes; they are normal byproducts of
ceilular respiration and are produced by ceils of the immune system to combat foreign
organisms. In addition, exogenous agents such as a subset of solar waveiengths and a
number of drugs and metals also generate ROS. Consequently, celis have deveioped a
number of methods of containing the damaged caused by ROS, including the Base
Excision Repafr pathway, the primary une of defense against oxidative DNA damage,
which prevents the accumulation of irreversibie mutations. Therefore, celis in which
these mechanisms are altered have increased susceptibiiity to ROS-induced damage.
Indeed, a variety of conditions and diseases, such as cardiovascular and
neurodegenerative diseases, diabetes, and cancer have been associated to oxidative stress.
Therefore, the study of genes involved in the cellular response to ROS may achieve a
greater understanding ofthe biology ofthese diseases.
In searching for genes that are involved in the response to oxidative stress, our
laboratories have previously identified the yeast homologue of the human Phosphotyrosyl
Phosphatase Activator (PIPA) gene as playing an important role in maintaining the
integrity of DNA in response to oxidative stress. Although studies have flot yet revealed
its specific function or mechanism of action, data suggest that PIPA may have a number
of important cellular functions, many of which are consistent with a function of PIPA in
pathways related to carcinogenesis. Given the ciinical importance of oxidative stress in
certain types of cancer as well as PIPA’ s involvement in maintaining DNA integrity, our
laboratories sought to elucidate this gene’s function in mammals by generating PTPA
knockout and transgenic mice. Recent advances that aliow for a high degree of
“tailoring” of the mouse genome have prompted us to design a targeting vector that wiil
enable the generation of “conditionai” knockout mice. In addition, we have produced
animais having integrated a DNA constmct which was anticipated to express the Ptpa
protein fused with a variant of the Green Fluorescent Protein within thefr genome,
although these did not express the transgene per se. When mouse mes with the Ptpa
VI
deletion and overexpression wiil be estabiished, these animais can be exposed to
oxidative stress-causing agents. It is expected that these experiments wiiI further oui
understanding ofthis gene’s foie in the response to oxidative stress.
Keywords: PTPA, RRD1, oxidative stress, UVA, DNA damage, transgenic mice,
knockout mice, cre-loxP, green fluorescent protein
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21. Introduction
1.1. Oxidative stress and disease
1.1.1. The Oxygen Paradox
Oxygen is a mixed blessing for aerobic life. On the one hand, it is essential for
cellular respiration and energy metabolism. Yet this molecule can become a potent agent
capable of causing significant damage to various macromolecules. Denham Harman
(1956) first developed the notion that oxygen can be detrimental to the ceil,
hypothesizing that oxygen free radicals are involved in general cellular damage,
mutagenesis, cancer and aging. Since then, this hypothesis lias been extensively
researched (Droge, 2000; Behrend et al., 2003), and many other conditions are cunently
associated with oxygen cytotoxicity, including neurodegenerative and heart diseases
(Lebovitz et aï., 1996; Norata et al., 2003) and diabetes (Nath et al., 1984).
Oxygen molecules become toxic when thefr metabolites are activated, via a series
of intercellular chemical reactions, into free radical reactive oxygen species (ROS), or
molecules with an unpafred electron in their outer valence sheil. ROS can be very
unstable and highly reactive, “attacking” neiglibouring, generally non-radical, molecules
in seeking to fil their valence sheli. In the process, reactive oxygen species damage the
“donor” molecules, effectively transforming these into ftee radicals, which in turn, will
also seek to fr11 their outer valence shell. Thus, a single free radical can cause a chain
reaction, potentially damaging multiple cellular components (Turrens et al., 2003).
1.1.2. Cellular Toxicity of ROS
Reactive oxygen species cause damage to cellular lipids, proteins and DNA. ROS
mediated lipid peroxidation could dismpt the fluidity and permeability of the cytoplasmic
and mitochondrial membranes, interfering with the proper functioning of membrane
bound proteins (Van der Vliet and Bast, 1992). Reactive oxygen species can also disrupt
protein flmction by causing site-specific amino acid modifications, altering proteic
electrical charge or triggering peptide fragmentation (Grune et al., 1997). Finaliy, ROS
can produce a variety of DNA lesions, inciuding modified bases (Téouie and Cadet,
31978), oxidized apurinic/apyrimidinic sites (Mitra et al., 2002) and strand breaks
resulting from damage to the sugar moiety of DNA (Dizdaroglu et al., 1975). These
damages can eventually give rise to permanent mutations (Loeb and Preston, 1986). One
frequent oxidative DNA lesion is the 7,8-dihydro-8-oxoguanine (8-oxoG) (Groilman and
Moriya, 1993). Lefi unrepaired, this premutagenic lesion can become an irreversible
OEC—*TA transversion (Shibutani et al., 1991; Cheng et al., 1992). Interestingly, such
transversions are ofien present in cancerous ceils, particularly in oncogenes and tumour
suppressor genes (Aguilar et al., 1993; Jones et al., 2004; Yokota and Kohno, 2004).
Another example ofthe mutagenic effects ofROS, is the deamination of normal cytosine
nucleic acids into the premutagenic 5-hydroxyuracil and uracil glycol lesions, which can
lead to a CG—*TA transition if left unrepaired (Kreutzer et al., 1992).
Oxygen free radicals are ofien so reactive that they do not diffuse more than a few
molecular diameters before reacting with another molecule (Pryor et al., 1996). Thus, the
damage localized within the nucleus is probably the result of free radicals produced later
in the free radical chain reaction. In fact, quantitatively speaking, it has been estimated
that DNA may be the least significant target of ROS (Mamett, 2000). Nonetheless, it is
estimated that one human cell produces up to 10,000-20,000 oxidative DNA lesions in a
24-hour period (Ames et al., 1993; Jackson and Loeb, 2001). In addition, damage
incurred by DNA is qualitatively of great significance because; whereas other cellular
components can be newly synthesized when damaged, unrepaired DNA can Jead to
permanent and irreversible mutations.
1.1.3. Sources 0f ROS
It would be expected that organisms would seek to minimize their
exposure to reactive oxygen species. However, the formation of ROS is neither abnormal
nor rare. As mentioned, ROS produced by mitochondria are natural by-products of
cellular respiration, continuously and inevitably endangering celis (Cadenas and Davie,
2000). Further, higher eukaryotes actively produce oxygen free radicals. Neutrophils
and macrophages exploit free radical toxicity by generating ROS as a means of
destroying foreign bodies during inflammation (Chong et al., 1989; Roos et aÏ., 2003).
4In addition, humans are exposed to a variety of exogenous sources of oxidative
stress, including ionizing radiation (Ward, 1989), cigarette smoke (Churg, 2003), trace
metals found in industrial waste, such as lead, mercury and cadmium (Ercal et al., 2001),
and various therapeutic and experimental drugs such bleomycin and adriamycin (Kappus,
1987) and the model carcinogen, 4-NQO (Ramotar et al., 1998). Oxidative stress is also
generated upon exposure to the ultraviolet (UV) subset of solar radiation. The sun emits
1.3V light of ail wavelengths, commonly categorized as UVA (400 nm - 320 nm), UVB
(320 run - 290 nm), UVC (290 nm
- 100 nm) Although UVC is extremely genotoxic, it is
not a major public health concem because wavelengths of less than 300 nm are largely
absorbed by ozone in the stratosphere before it reaches the Earth (Latarjet, 1935).
Consversely, UVA and UVB wavelengths reach the Earth. These generate chemically
distinct types of DNA damage these wavebands. However, both UVA and, to a lesser
extent, UVB, can generate R0$ (Cadet et al., 2005). Thus, these exogenous sources of
ROS are compounded to the endogenous “load” constantly challenging the integrity of
the celi.
1.1.4. Cellular Defence Against ROS Insuit
Organisms have adapted to the continuous and unavoidable exposure to oxygen
free radicals by developing several strategies to attenuate ROS cytotoxicity. Various
superoxide dismutase (SOD), catalase and glutathione peroxidase enzymes constitute an
important me of defence. Briefly, SOD can convert two superoxide radicals (02) into
less reactive hydrogen peroxide (H202) (Noor et al., 2002), which is subsequently,
converted into water and oxygen in a process mediated by catalase and glutathione
peroxidase (de Haan, 1995). In addition, higher eukaryotes produce antioxidants,
molecules that provide free radicals with an electron to fil their outer valence sheil
(Jacob and Burri, 1996). Together, these mechanisms allow the celi to contain the effects
of oxygen free radicals.
However, preventative measures are insufficient to protect the integrity of DNA,
which camiot be newly re-synthesised once mutations have incurred. Consequently, celis
have developed mechanisms to repair oxidative lesions before these become permanent
mutations. Most important is the Base Excision Repafr (BER) pathway, in winch a
5variety of proteins acts sequentially to remove the base and sugar moieties of the
damaged nucleic acid, incorporating the appropriate undamaged nucleic acid in its place.
Briefty, a DNA glycosylase is recruited to the site of the lesion, disassociating the base
from the sugar moiety of the nucleic acid and creating an apurinic/apyrimidic (AP) site
(Figure 1). Subsequently, an AP endonuclease disrupts the sugar backbone, leaving
bebind a gap in the double stranded structure of the DNA. This gap is filled by a DNA
polymerase, and the newly ïncorporated nucleic acid is ligated to the DNA by a ligase
(Fortini et al., 2003).
Damaged base
AP site
Repaired DNA
DNA glycosylase
]1E
—11
AP endonuclease
HE5LSL5 E5JJJ
JJ 1
DNA polymerase
DNA ligase
EIL5JJ
Figure 1: Base Excision Repair pathway. This is the most important for the
repair mechanism of oxidative DNA lesions
6The repafr proteins, such as DNA glycosylases and AP endonucleases, are
relatively well conserved in organisms (Barziiay and Hickson, 1995; McCullough et aï.,
1999). Studies in yeast and mammalian ceils have demonstrated that ceils with a
deficiency in one or several of these genes show an increase in premutagenic lesions and,
sometimes, a hypersensitivity to oxidative stress-inducing agents (Waiker et al., 1994,
Doetsch et al., 2001, Kim et al., 2002).
Aithough BER is the primary response to oxidative stress-induced DNA lesions,
other mechanisms aiso contribute to the repair of these lesions. For example, UVC
generates dipyrimidine photoproducts lesions (chemicaily distinct from oxidative lesions)
which are primarily repafred by the Nucleotide Excision Repair (NER) pathway.
Nonetheless, there is some overlap of these repair pathways; the NER and other repair
mechanisms contribute to the repafr of oxidative DNA lesions, albeit to a lesser extent
relative to the BER (Scott eÏ al., 1999, Rybanska and Pfrsei, 2003).
1.1.5. Mutagenic effect of ROS and Melanoma
Oxidative damage to DNA may be a significant factor in the dramatic increase of
melanoma incidences rates in North America, Europe and Australia in the 1 970s and
1 908s (Arrnstrong and Kricker, 1994, Hall et al. ,1999). The higffly mutagenic UVB
component of solar radiation has long been established as the major cause of this disease
(de Gruiji, 2000). However, there is a growing consensus that solar UVA plays a more
significant role in the development ofmelanoma than was first thought. This is supported
by several experiments conducted in murine and human celi mes, whole animais, as well
as a number of epidemiologicai studies (Jones et al., 1987, Lundgren et al., 1988,
Sterenborg and van der Leun, 1990, Setiow et al. 1993, and Ley, 1994). In addition,
various mes of evidence indicate that oxidative stress plays a significant role in
cutaneous carcinogenesis. For example, it has been demonstrated that normal
melanocytes from melanoma patients have increased sensitivity to peroxidizing agents
(Grammatico et al., 1998), that the skin antioxidant defense system is impaired in
melanoma celis and normal melanocytes of these patients (Picardo et al., 1996). Further,
antioxidant supplementation was found to have a photoprotective effect on ceils (Lopez
Torres et al., 1998). Another study demonstrated that compounds that generate oxygen
7free radicals increase the effect of malignant conversion of cancerous skin celis (Athar et
al., 1989). The authors of ffiis report present the hypothesis that the accumulation of
genetic lesions and strand breaks and chromosomal aberrations induced by ROS hasten
the process by which celis become malignant.
Thus, although UVB is incontestably more genotoxic than UVA and remains the
major factor in the incidence of melanoma, there is growing evidence that UVA-induced
reactive oxygen species may play a role in this carcinogenesis that is more significant
than was initially thought.
1.2. The Involvement of the Phosphotyrosyl Phosphatase Activator
Gene in the Response to Oxidative Stress
1.2.1. Identification of Genes with a Rote in the Response to Oxidatïve Stress
Given the significant impact of oxidative stress upon human health, our
laboratories were interested in identifying novel genes that perform key fimctions in the
cellular response to this type of stress, particularly those that play a role in the repair of
ROS-induced DNA damage. Jnitially, the budding yeast Saccharomyces cerevisiae was
chosen as the organism in which to conduct this search because its genome is well
characterized and relatively easy to manipulate. In addition, fundamental processes,
including DNA repair pathways, are weIl conserved from yeast to humans. Isolating
oxidative stress response genes in yeast could lead to the identification of novel functions
ofnew or previously characterized genes in humans.
As described by Ramotar et al. (1998), a wide panel of yeast mutants were
subjected to a three-step screen. Initially, mutants showing hypersensitivity to 4-
nitroquinoline 1 -oxide (4-NQO) were isolated. This drug generates two different types of
DNA damage: genotoxic “bullcy” lesions, primarily repaired by NER, and oxidative DNA
lesions, primarily repafred by the BER pathway. Mutants obtained from this initial screen
were expected to demonstrate hypersensitivity to 4-NQO due to defects in a number of
mechanisms, including the NER and BER pathways. To differentiate the ROS-response
mutants from the ones with other defects, the 4-NQO hypersensitive strains were exposed
to UVC (254 nm UV light). The mutants showing full cross-sensitivity to the genotoxic
8effects of UVC were precluded from further study because these were likely to carry
defects in the NER. Conversely, the mutants exhibiting normal sensitivity to UVC were
retained. The latter carried mutations in candidate genes having a RO$-specific function.
Ihe fmal step consisted of characterizing these yeast strains, identifying the mutated
genes and confirming ffieir role in the cell’s response to oxidative stress.
1.2.2. PTPA Involvement in Maintaining DNA Integrity upon Exposure to
Oxidative Stress
When the mutants were characterized, it was found that several ROS
hypersensitive strains carried a mutation on RRD 1, one of the two yeast homologues of
the human Phosphotyrosyl Phosphatase Activator (PIPA). Ihis gene was subsequently
deleted in various wild-type yeast backgrounds and exposed to different oxidative stress
inducing agents. In addition to the previously observed hypersensitivity to 4-NQO,
RRD1-defecient ceils were hypersensitive to other ROS-inducing agents including UVA,
UVB, and diamide. Conversely, these strains were not hypersensitive to genotoxic agents
that do flot cause oxidative stress, such as 254 nm-UV. further, genetic complementation
tests were performed by transforming RRD 1 -deficient yeast celis with vectors driving the
constitutive expression of RRD 1. This successfiilly restored normal UVA and 4-NQO
resistance. It was also shown that strains lacking RRD1 exhibited a hypermutable
phenotype in normal conditions, as well as an increased frequency of chromosomal
breakage in comparison to wild-type strains. This phenotype was exacerbated when ceils
were treated with 4-NQO. Together, the data strongly suggested that Rrdl plays a role in
maintaining the integrity ofDNA in celis challenged with oxidative stress.
1.2.3. Complexity of PTPA Functions
Although PIPA, the mammalian homologue of yeast RRD1, has been the subject
of numerous studies since it was identified in 1990, very little is known about its
function. The Ptpa protein was found to be an activator of protein phosphatases of type
2A (PP2A), a family of phosphatases that is both structurally complex and
multifunctional. Much like PP2A, PIPA seems to 5e involved in a multitude of
paffiways. Its complexity has rendered focused and precise studies difficuit to perform.
9In addition, two recent reports have showed that this gene activates a broad spectrum of
PP2A’s activities (fellner et aï., 2003; Longin et al., 2004), contrary to what had been
assumed for over a decade. Accordingly, hypotheses and speculation of possible roles of
PTPA have, until recently, been based on data that was later shown to be false. It is in
the context of the complex functions of PP2A and PTPA and erroneous assumptions
conceming Ptpa’s biochemical function as a PP2A activator that the ftagmented literature
on this gene should be surveyed. Although no clear model of Ptpa action mechanism
emerges from the literature, it does not negate the fmding that this gene plays an
important role in maintaining DNA integrity in response to ROS insuit. Rather, the sum
of Ptpa-related data indicates that this protein is involved in a number of cellular
processes, a subset ofwhich is associated with mutagenesis and carcinogenesis.
1.2.3.1. PP2A Proteins are Multifunctional Phosphatases Involved in Carcinogenesïs
Protein phosphatases of the family 2A are multifaceted at the biochemical and
structural levels. Thefr primary biochemical function is to dephosphorylate
phosphorylated serine and threonine residues (Waellcens et al., 1987). However, PP2A
also exhibits a low basal level of phosphotyrosine phosphatase activity (Chemoff et al.,
1983; Fouilces et al., 1983). Conserved in organisms, PP2A is structurally complex.
Minimally, the phosphatase exists as a dimer consisting of a C-catalytic subunit and an
A-structural subunit. Both of these subunits can exist in two isoforms in mammals
(Mayer et al., 1991; Groves et cil., 1999). This core dimer can associate with a regulatory
component, subunit B, to form a trimeric holoenzyme. This subunit, made up of four
distinct families (B, B’, B”, B”) and their isoforms (Gentry and Hallberg, 2002), is
involved in targeting the PP2A holoenzyme to the appropriate cellular compartment and
in providing substrate specificity (Zolnierowicz et al., 1996). In addition to these, a
number of subunits that are stmcturally and fimctionally similar to PP2A exist. These
PP2A-like proteins include PPP6C, the mammalian homologue of S. cerevisiae SIT4
(Bastians and Ponstingi, 1996, Bastians et al. 1997). Only a few holoenzymes of PP2A
have been isolated in humans, but it has been estimated that more than 40 different
combinations oftrimeric complexes could be formed (Janssens and Goris, 2001).
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The phosphatas es of type 2A in lower organisms share many, but flot ail, of these
features. For example, in contrast to mammalian PP2A, S. cerevisiae has numerous C
subunits, but these do flot have known functional isoforms. In addition, there are fewer B
subunits, and consequentiy there are far fewer possible holoenzyme combinations
(Gentry and Haiiberg, 2002).
It appears that the various components of the holoenzymes and thefr isoforms
have some partially non-redundant functions. An exampie of this in yeast arises from a
genetic study involving the deletions of the S. cerevisiae B-subunits CDC55 and RTS1,
which demonstrated that CDC55-deficient strains exhibit defective cytokinesis and
abnormal ce!! morphology while RIS 1 -deficient strains are temperature sensitive. It was
also shown that the over-expression of one gene did flot compensate for the deletion of
the other (Zhao et al., 1997), further indicating that these B-subunits are involved in
distinct pathways.
Even isoforms of a given subunit may have non-redundant functions. A striking
example ofthis was provided by Gitz et al. (1998), who demonstrated that the f3 isoform
of subunit C could flot compensate for the embryonic lethality phenotype observed in the
targeted deletion of the a isoform in mice, despite thefr strong homo!ogy (97% amino
acid identity).
Given the number of potential holoenzymes and the possibility that these have at
least partialiy non-redundant fimctions, it is not surprising that PP2A is associated with a
variety of biological processes including the celi cycle (Karaiskou et al., 1999), DNA
replication (Lin et al., 1998), transcription (van Zyi et aÏ., 1992), RNA spiicing
(Mermoud et al.,1998), translation (Di Como et al., 1996) and morphogenesis (Healy et
al.,l 991; Heiler et al. ,1998). In addition, PP2A is an important cellular target of invading
toxins and viruses (Garcia et al., 2000).
There are various unes of evidence associating PP2A with cancer. For example,
okadaic acid, a strong inhibitor of PP2A activity has been found to promote tumour
formation in the skin of mice (Suganuma et al., 1988), and a number of studies have
demonstrated loss-of-function mutations in A-subunit isoforms of patients with lung and
breast carcinomas and colorectal and colon cancers. (Wang et aÏ.; 1998; Takagi et al.;
2000; Calin et al., 2000; Ruediger et al., 2001). Further, PP2A bas been found to
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facilitate the cellular response to oxidative stress by dephosphorylating members of the
retinoblastoma (Rb) family of tumour suppressor proteins. These proteins have a variety
of fimctions including regulating the E2F transcription factor. This regulation plays an
important role in mediating the events leading to the progressionlarrest of the ceil cycle
(Muller et al., 2000). Cicchillitti et al. (2003) demonstrated that upon exposure to
hydrogen peroxide, a drug that generates significant levels of oxidative stress, PP2A acts
to dephosphorylate Rb proteins, causing E2F to arrest ceil growth. This phosphatase is
also involved in melanoma; a mutation of the B subunit 56y-l gene was shown to
exacerbate the progression of this cancer (Ito et al., 2003). Thus, PP2A is involved in a
number of pathways, a subset of which is consistent with a role in carcinogenesis,
melanoma progress and the response to oxidative stress.
1.2.3.2. PTPA: A Survey of the Literature
Initially, most research relating to Ptpa sought to elucidate its biochemical
function as an activator of PP2A. Later reports focused primarily on genetic and
proteomic features of PTPA in different organisms, and more recent studies have
principally elaborated on its function at the cellular level. Whereas the biochemical
literature has flot led to any real understanding of Ptpa’s role in the ceil, a number of
important features and phenotypes have been identffied.
1.2.3.3. Biochemical Funcfions of Ptpa
As mentioned, PP2A can exist as a dimer or trimer, and has two phosphatase
activities. It is primarily a Ser/Thr phosphatase, but also exhibits a basal level of tyrosyl
phosphatase activity (Chemoff et al., 1983, Fouikes et al., 1983). Initial in vitro assays
identified Ptpa as an activator of the tyrosyl phosphatase activity of the dimeric form of
PP2A. These assays excluded the possibility of PTPA activating the trimeric holoenzyme
(Cayla et al., 1990) or being involved in the SerlThr phosphatase activity of PP2A.
Consequently, early studies involved determining the effect of Ptpa on subunits A and C
of PP2A only. However, two recent studies indicate that these assumptions were
incorrect; PTPA’s main function was found to be the activation of the Ser/Thr
phosphatase activity of the PP2A trimeric holoenzyme in vivo (feliner et aï., 2003;
Longin et al., 2004). Both reports propose different biochemical models in which Ptpa
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regulates the C-subunit’s activity by mediating conformational changes of PP2A.
However, these fmdings are flot defmitive and it is unclear if tliey will be instrumental in
defming a cogent biological function for PIPA.
1.2.3.4. Ptpa Protein is Conserved in Organîsms
Homologous Ptpa proteins have been identified in S. cerevisiae (Rrdl and Rrd2),
S. pombe (Accession Z98980), Drosophila melanogaster, Xenopus laevis (Van Hoof et
al., 199$), as well as many mammals ranging from the rabbit, mouse and dog to humans
(Cayla et al., 1990; Cayla et al., 1994; Van Hoof et al., 1994). Mammalian Ptpa appears
to be ubiquitous; the protein is present in the brain, liver, kidney, muscle, spleen,
pancreas and fat celis of the rabbit and dog (Cayla et al., 1994) as well as various
independent ceil unes derived from mice and humans (Cayla et al., 1994; Fellner et al.,
2003).
There are some significant differences between the Ptpa proteins of the different
organisms. For instance, although mammalian Ptpa proteins are highly homologous to
each other (for exampie, 97% amino acid identity is observed between human and rabbit
Ptpa), iess similarity is observed between mammalian proteins and those of lower
eukaryotes (for example, 50% homology is observed between drosophila and human
Ptpa). In addition, S. cerevisiae and drosophila proteins are considerably larger than thefr
orthologues in vertebrates; whereas the latter are 37 kDa, the former contain an extended
10 kDa C-terminal tau (Van Hoof et al., 199$). Nonetheless, certain regions are highly
conserved in ail organisms (Figure 2). Van Hoof et al. (199$) demonstrated that these
regions have fimctional significance by showing that targeted deletions of the conserved
areas altered PTPA activity in vitro. Further, genetic complementation studies, in which
RRD1-deficient yeast strains were transformed with a vector driving the expression ofthe
mammalian Ptpa protein successfully reversed some phenotypes of the mutant strain
(Douville et al., 2004).
Ihe presence of Ptpa is crucial to celi survival; yeast strains deficient in both
PIPA genes are not viable (Rempola et al., 2001) and ifie inhibition of Ptpa translation
by RNA interference causes mammalian celi mes to undergo apoptosis (Feliner et al.,
2003).
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H- Ptpa MAEGERQPPPDSSEEAPPATQNFI IPKKEIHTVPDMGKWKRSQAYADYIGFILTLNEGVK 60
M- Ptpa MAEGERQPPPDSSEETPPTTQNFI IPKKEIHTVPDMGKWKRSQAYADYIGFILTLNEGVK 60
D-Ptpa MASGINQAAG KLPAIA KKVQNLGDMGVWQKSRAFHDLIGYINGTSSAIQ 49
C-Ptpa MAENSYKPPE KMIIDWFDLNPWYFSKAYEEYLAFLHRLNDSW 43
Y-Rrd2 MLPE KRLLTPDDMKLWEESPTRAHFTKFIIDLAESVK 37
Y-Rrdl MSLDRVDWPHATFS TPVKRIFDTQTTLDFQSSLAIHRIKYHLHKYTTLIS 50
H-Ptpa GK- - -KLTFEYRVSEAIEKLVALLNTLDRWIDETPPVDQP- -SRFGNKAYRTWYAKLDEE 115
M- Ptpa GK- - -KLTFDYKVSEAIEKLVALLDTLDRWIDETPPVDQP- -SRFGNKAYRTWYAKLDQE 115
D- Ptpa GI - - -KTTDEIFESEMLKKLLRLFDALEKLVEQNPPLEQP- -QRFGNKAYRDWAQAI4REL 104
C-Ptpa GV- - -HTTAMRCTDLVISFIDMLDLEKWAEEIPLEDVSE-QRFGNKAYRKFYEKLCKE 99
Y-Rrd2 GHE- -NSQYKEPISESINSMMNLLSQIKDITQKHPVIKDADSSRFGKVEFRDFYDEVSRN 95
Y-Rrdl HCSDPDPHATASSIAMVNGLMGVLDKLAHLIDETPPLPGP- -RRYGNLACREWHHKLDER 108
H-Ptpa AENLVATWPTHLAAAVPEVAWLKESVG IDYGTG FAAFLCCLCKIGVLRV- 174
M-Ptpa AENLVATWPTHIJAA.AVPEVAVYLKEAVG TRIDYGTG FAAFLCCLCKIGVLRV- 174
D-Ptpa LPELLEQLLPDDKKRYQVELGQYLTESFG TRIDYGTG LSFLFFLCSLFKAEILQE- 163
C-Ptpa SPDLLASVLPENVHDALVELVPYFTESFG TRIDYGSG FLILLFCLQKLGVFTE- 158
Y-Rrd2 SRKILRSEFPSLTDEQLEQLSIYLDESWG IDYGSGH LNFMCLLYGLYSYGIFNLS 155
Y-Rrdl LPQWLQEMLPSEYHEWPELQYYLGNSFGS RLDYGTGHELSFMATVAALDMLGMFPH- 167
H- Ptpa DDQIAIVFIWFNRYLEVMRKLQKTYRNEPAGSQGVWGLD FQFLPFIWGSS- - -QLIDHP 231
M-Ptpa DDQVAIVFKVFDRYLEVMRKLQKTYRMEPAGSQGVWGLD FQFLPFIWGSS---QLIDHP 231
D-Ptpa RDIVSAALRRFNRYLEVARQLQRTYNNEPAGSQGVWSLD FQFVPFIWGSA- - -QLAVKS 220
C-Ptpa NDDICVLVLRIFNKYLRVCRHLQTRFIGIEPAGSRGW{AID FQFAPFIFGSA- - -QLIGSK 215
Y-Rrd2 NDSTNLVLIWFIEYLKIMRILETKY4EPAGSHGVWGL YHFLPFLFGAF- - -QLTTHK 212
Y-Rrdl -MRGADVFLLFNKYYTIMRRLILTYTfrPAGSHGVWGLD HFHLVYILGSSQWQLLDAQA 226
H-Ptpa YLEPRHFVDEKAVNENHKDYMFLECILFITEMKTGP-FAEHSNQLWNISA-VPSWSKVNQ 289
M-Ptpa HLEPRHFVDEKAVSENHKDYMFLQCILFITEMKTGP- FAEHSNQLWNISA-VPSWSKVNQ 289
D-Ptpa PFDPSKFVDEAIITEYKDHFMFISCIDYICKVKTGH-FGEHSNQLWSITD-VPTWAKINA 278
C- Ptpa SIVPDSYLKIQHVETHAHTSLFLDCVNFINQTKTGP- FHEHSNQLWNISA-VPHWKKVNS 273
Y-Rrd2 HLKPISIHNNELVEMFAHRYLYFGCIAFINKVKSSASLRWHSPMLDDISG-VKTWSIWAE 271
Y-Rrdl PLQPREILDKSLVREYKDTNFYCQGINFINEVKMGP-FEEHSPILYDIAVTVPRWSKVCK 285
H-Ptpa
M-Ptpa
D-Ptpa
C-Ptpa
Y-Rrd2
Y-Rrdl
H-Ptpa
M-Ptpa
D- Ptpa LVPPVPVATAPPPPAESLSIEQNVGDSSSESSDNSVVLRPSTSSSSLVAAAEGSGDKPSKE 397
C-Ptpa FKIPS-AANTSTVHSSSWESGDLRRLHSEKHPNEHCPPPMADA 375
Y-Rrd2 DDECNFEGHVHTTWGDCCGIKLPSAIAATEMNKKHHKPIPFD 358
Y-Rrdl QTSTRFPTSTSMPPPGVPPSGNNINYLLSHQNQSHRNQTSFSRDRLRR 393
Figure 2: Ptpa is conserved in organisms. Human (H), mouse (M) D.
melanogaster (D), C. elegans (C), both S. cerevisiae (Y) proteins.
Highlighted sequences correspond to highly conserved regions. Amino acids
I KAECLE1
I KAECLF
QKE IL:
F EGEVLI
KAEVU
SVEVLI
FKFGS-LLPIHPVTSG 323
FKFGS-LLPIHPVTSG 323
VYFGE-LMTFEPVSSGTTLSNALLGIWAPPPSKRICIGTPN 337
4MFGS - LFSFDRSEHPRESMEDAPSQDPMPPRAPAQHGMFA 332
FYFSE-FLPCPDGVS PPRGHIHDGTDK 316
FWFGTGFFPWVNIQNGTDLPVFEEKEEESIEQANAGSPGRE 345
in bold correspond to the targeted sequence (see section 4.1.5).
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The ubiquity of Ptpa expression in mammalian tissues, the presence of the highly
conserved regions and the apparent necessity of this protein for ce!! survival in yeast and
mammalian celi unes indicate that Ptpa performs vital cellular functions.
1.2.3.5. Genetic Features of PTPA
The coding sequence for the human PTPA gene was found to be localized at
chromosome 9q34, spanning 60 kb. The genomic sequence consists of 10 exons and 9
introns. The promoter region lacks the traditional TATA sequence for transcription
initiation. However, it was observed that several features of housekeeping genes are
present in the PTPA promoter sequence (Van Hoof et aÏ., 1995). For example, many
housekeeping genes have a 200-1000 bp unmethylated, typically GC-rich, CpG island
spanning the promoter region, frequently extending into the first exon (Bfrd, 1986).
Accordingly, the PTPA promoter sequence has an average GC content of more than 70%
and an unmethylated CpG island well into ils first exon (from position -159 to +91)
(Janssens et al., 1999). Although the promoter sequence was found to have many
putative binding sites for a variety of transcription factors (including Myc, NF-cB and
Myb), only the Yin Yang 1 (YY1) transcription factor was found to bind PTPA’s
promoter sequence to initiate transcription (Janssens et al., 1999). Interestingly, this
transcription factor has been associated with cervical and breast cancer (Dong et al.,
1994; Nayak and Das 1999) as well as hepatocarcinogenesis (Parija and Das, 2003).
Finally, several alternative spiicing products of Ptpa (transcripts P-ri) were
identified, of which only the f3 transcript was detected by western blotting (Janssens et
al., 2000). However, in vitro assays revealed that this product did not activate the tyrosyl
phosphatase activity of PP2A. It was thus concluded that these products have !imited
biological function and are the resuit of spiicing errors. The more recent data indicating
that Ptpa activates the Ser/Thr phosphatase activities now casts doubt on this resuit; Ptpa
f3 may well have a functiona! role in vivo.
1.2.3.6. PTPA’s Role in Response to Oxidative Stress and in Pathways Related to
Carcinogenesis
Douville et al. (2004) have recently confirmed that Rrdl plays a role in the
response to oxidative stress and have demonstrated that this function is dependent upon
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Rrdl interaction with Sit4, a yeast PP2A-lilce catalytic subunit. Jndeed, yeast strains
deficient for Rrdl, Sit4, or both exhibit equal sensitivity to 4-NQO, indicating that these
proteins function in a common pathway. Further, these two proteins were found te
physicaily interact with each other. Despite this progress, no clear mechanism of action
can be assigned to Ptpa. Stili, several unes of evidence support the notion that PTPA is
invoived in carcinogenesis.
The p53 tumeur suppressor gene was found te be a target of Ptpa. This gene
represses PTPA transcription by binding to its TATA-less minimal promoter, preventing
the YY1 transcription factor from binding te the region (Janssens et al., 2000). Indeed,
p53 is known te repress the transcription of a number of genes by binding their TATA
less promoters (Kley et al., 1992, Sandri et aÏ., 1996).
In addition, numerous studies have aise associated Rrdl te the celi cycle in yeast,
aithough its precise foie 5 stiil a subject of controversy. Dr. Gens’ group have pubiished
data suggesting that Rrdl functions in negative regulation through Start (Van Hoof et al.,
2000), exciuding involvement in the G2/M transition (Van hoof et al., 2000).
Conversely, Mitcheil and Sprague (2001) found that Rrdl does function in the G2IM
transition and that it may play a noie in the positive reguiation of Gi. Thus, aithough it is
unciear how and at what stage, PIPA appears te be involved in the progression ofthe celi
cycle.
Another une of evidence linking PTPA te cancer is a proteomic analysis of a
human hepatoceiiuiar carcinoma ceii une HCC-M. The study reveaied a number of
preteins that were expressed at abnormai ieveis in these celis, including Ptpa (Ou et ai.,
2001). Interestingiy, this proteomic anaiysis aise detected thioredoxin peroxidase (Seow
et ai., 2000), an important enzyme in regulating the intraceliular redex envirenment
(Gasdaska et ai., 1995). Altheugh preiiminary, given the reiationship of oxidative stress,
DNA damage and chronic inflammation with the increased risk ef liver cancer (Wang et
ai, 2002; Ichiba et aÏ, 2003), the data is fuliy consistent with PTPA’s putative function in
the celiular response te oxidative stress.
In addition, the chromosomal location of the human PTPA gene on chromosome
9q34 may be a corroborating factor. This region contains genes associated with a number
ef diseases such as bladder cancer (Kimura et aÏ. 2001), several types of leukemia
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(Kaneko et al., 1988; von Lindem et al. 1990; Huntly et al., 2003), as well as
amyotrophic lateral scierosis (Chance et al., 1998).
Together with the data on PP2A, the literature supports a role for PIPA in the
cellular response to oxidative stress as well as ffie cellular processes associated with
carcinogenesis.
1.2.3.7. Phenotypes Associated witli PIPA
Given the broad spectrum of cellular processes in which PP2A is involved, it is
not surprising that Ptpa, too, has many functions. lndeed, Ptpa is implicated in a number
ofpathways that appear unrelated to its role in maintaining DNA integrity in the response
to oxidative stress. For example, yeast ceils deficient in RRDÏ or RRD2 display
phenotypes similar to those observed in yeast strains deficient in PP2A subunits. Most
notably, deletion of RRD1 causes defects in bud morphology formation that are similar
to the ones obtained in strains with a deletion oftwo yeast PP2A catalytic subunits, PPH1
and PPH2. Yeast strains carrying a deletion of the RRD2 gene exhibit altered
microtubule dynamics, resembling ifie phenotype obtained upon deletion of a PP2A
regulatory B, CDC55 (Van Hoof et ai, 2001). In addition, Rrdl and Rrd2 aiso fimction
in the HOG1 kinase pathway (Rempola et al., 2000), which is essential for mediating
cellular response to increased extemal osmolarity (Brewster et al., 1993), again unrelated
to the response to RO$.
Finally, Ptpa aiso functions in the TOR (Target of Rapamycin) pathway in S.
cerevisiae. li yeast, this compiex pathway is important for sensing nutrient availability
before initiating cellular division. Thus, the proteins in this pathway regulate translation
initiation, ribosome biosynthesis (Powers and Walter, 1999), transcription of numerous
enzymes involved metaboiic pathways (Schmelzie and Hall, 2000), and amino acid
import (Beck et al., 1999). Rapamycin mimics nutrient deficiency, causing yeast ceils to
arrest growth and to behave physioiogically as if they were starved, via the TOR
pathway. However, celis lacking RRD 1 are resistant to the starvation mimetic affect of
rapamycin (Rempola et al., 2000). This suggests that the Ptpa protein may be centrai to
the compiex TOR pathway.
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These cellular pathways are, apparently, unrelated to each other. However, the
accumulation of unrelated fmdings conceming Ptpa’s fiinctions may eventually help
shape an understanding of its broader fimction. For example, Ptpa’s involvement in the
TOR pathway may shed light on its fimction within the response to oxidative stress. Di
Como and Arndt (1996) have demonstrated that Sit4, ifie PP2A catalytic subunit found to
interact with Rrdl to respond to oxidative stress, is also a target of a protein known to be
implicated in the TOR pathway, Tap42. In addition, a number of studies have indicated
that dysreguiation of the Target of Rapamycin pathway generates “a favorable oncogenic
environment” (Huang and Houghton, 2003). Therefore, aithough it is not clear how this
network of complex interactions functions, later studies may demonstrate a convergence
of the different PTPA-related pathways.
1.3. Manipulating the Mouse Genome to Study Gene Function and
Disease
1.3.1 Genetically Modffled Mice
Genetic manipulation of mammalian celis has proven to be a useffli means of
smdying gene function. However, the refmement of moiecular biology techniques has
led to a growing trend of studying biological processes in laboratory animais. Most
widespread is the manipulation ofthe mouse genome, which enables studies on genes and
their impact on animal health relatively rapidly and at a low cost in comparison to
research on other mammals. Two of the most common methods used are the targeted
deletion and integration of specific genes into the mouse genome.
Creation of these mice consists of four essential steps: (i) the engineering of a
DNA construct; (ii) the integration of the construct within the genome of embryonic stem
(ES) celis or fertiiized oocytes; (iii) the transfer of these celis to a pseudo-pregnant
female who will then give birth to the genetically manipulated mice, and finally; (iv) the
strategic pafring of offspring to produce a colony of genetically modified mice.
There are major differences between the production of knockout and transgenic
mice. Typicaily, the former involves electroporating the DNA constmct into mouse ES
celis. The aim of this step is to replace endogenous DNA sequences with the constmct
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via homologous recombination (HR). Since this is a relatively rare event, ES celis must
5e carefulÏy selected before being transferred into a pseudo-pregnant female. Conversely,
creating transgenic mice requires the DNA construct to be microinjected directly into a
fertilized oocyte. There is no need to grow celis in vitro for selection since the
integration of the constmct DNA does flot need to occur at a specific locus (Cheah and
Behringer, 2001; Richa, 2001).
Despite these progresses, there is an ever-growing need to develop techniques that
will enable a higher degree of “tailoring” of the mouse genome. A number of
technologies have recently been developed, refming classical manipulation methods by
combining them with strategies that allow for greater versatility, such as conditional
targeted deletions and the use ofthe Green fluorescent Protein (GFP).
1.3.2 Conditional Knockout Mice
At the molecular level, the strategy used for gene targeting essentially consists of
modifying a specific portion of this gene, thought to 5e important for the proper
functioning of the resulting protein, via homologous recombination (HR). A crucial step
is the design of the targeting vector. The DNA construct must 5e designed to contain two
regions of high homology to the targeted gene for HR. These flank a sequence that
would disrupt the function of the translated protein. For example, one common approach
is to replace an important exon of the targeted gene with a marker for antibiotic
resistance. Upon electroporation of embryonic stem celis and homologous
recombination, the ES cells will carry an antibiotic resistance gene in lieu of this exon
(Figure 3), and will translate truncated, non-functional protein of the targeted gene.
The traditional strategy for targeted deletions has one major disadvantage: the
entire organism is defective for the specific gene throughout its development and in all
tissues. It may 5e difficult to design and perform precise experiments on animals in
which the gene disruption is ubiquitous. Worse, the targeted deletion could lead to
embryonic lethality, making it impossible to study gene function during the postnatal
period.
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Figure 3: Homologous recombination between the targeting vector and the
endogenous gene. A portion of the gene is disturbed by the integration of
the modified DNA constnict.
A method of circumventing these challenges is the creation of conditional
knockout mice, designed to carry the gene deletion in a subset of tissues andlor at a
moment in their lifespan chosen by the experimenter. Thus, temporal and spatial
conditional knockouts allow the knockout event to occur post-partum, preventing the
problem of embryonic lethality, andlor in specific tissues, enabling a more focused
expenmental design. Commonly used tools for developing such conditional knockouts
are the Cre/loxP and Flp/frt systems. The Cre/loxP system is based on a recombination
that occurs in bacteriophage Pi (Austin et aL, 1981). The Cre recombinase of this
bacteriophage recognizes and mediates recombination between two specific, 34 base-long
loxP sequences (Figure 4). In knockout studies, the targeting vector is engineered with
loxP sites flanking the sequences of the mouse genome that are to be deleted. In contrast
to traditional targeted deletions, the purpose of the homologous recombination between
the DNA construct and the genomic DNA in ES ceils is not to delete or disrupt sequences
in ail tissues, but rather, to incorporate the loxP, which will then facilitate the removal of
genomic sequences at a later time andlor in specific celi types. The loxP sequences are
engineered within the intron sequence so that these genomic modifications have littie
chance of altering the expression or activity of the resulting protein. These loxP-mice are
subsequently crossed with mice expressing the Cre recombinase, under either an induci
Genomic DNA
DNA construct
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Figure 4: The Cre recombinase mediates recombination between loxP sites.
This effectively deletes the loxP-ftanked sequences.
ble or a tissue-specific promoter (or both), resulting in mice carrying the loxP sites as
well as the Cre recombinase. The offspnng of this cross are wild-type with regards to the
targeted gene; only when and where the recombinase is expressed does the recombination
between the loxP sites finally occur, deleting the sequence flanked by loxP sites (Orban et
al., 1992). Thus, if the Cre recombinase is under the control of an inducible promoter,
the knockout event occurs only upon recombinase induction; if the promoter is tissue
specific but not temporally controlled, only this tissue type will become deficient for the
targeted gene throughout development. Tissues that are flot induced to express the
recombinase will express wild-type, full-length protein.
The Flp/frt system is based on S. cerevisiae (Broach and Hicks, 1980) and functions in a
manner that is analogous to the Cre/loxP system, the Flp recombinase mediating the
recombination between two 48 hp-long frt sites. The FlpIFrt approach is rather efficient
and used relatively frequently in cells lines. Although it is less commonly used for
generating conditional knockout mice because of certain technical restrictions, these
constraints are being gradually overcome (Rodriguez et al. 2000), maldng this a more
appealing system.
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1.3.3 The Use of Green Fluorescent Protein Variants in Mice
The use of ffie Green Fluorescent Protein (GfP), derived from the jellyfish
Aequorea victoria, has heiped create transgenic mice that are more versatile. The main
chemical and physical properties ofthe GFP were detailed in the late 1970s (Prendergast
et al., 1978) but it was flot for several years that it was used a tool for biological study in
other organisms, such as C. elegans (Chaffie et al., 1994), D. meÏanogaster (Wang et al.,
1994) and the zebrafish (Amsterdam et al., 1995). Ikawa et al. (1995) produced the first
transgenic mouse mes, having integrated the GFP gene in their genome and expressing
fluorescence in a variety of tissues.
The original GFPs’ relatively low emission and excitation spectra allow for
fluorescence observation upon exposure to a standard handheld UV lamp. In the iast
decade, many variants of this protein have been developed, each with slightiy different
characteristics. These GFPs can have several applications in mammais. They can be
expressed as tags on either the C or N terminais of proteins, and used as non-invasive
reporters of gene expression. In addition, the intensity of fluorescence can be used for
typing of transgenics (homozygote vs. hemizygote), and as a means for screening for
transgenic offspring at birth (Hadjantonakis and Nagy, 2001).
The applications are not limited to fluorescence visualization at the macroscopic
level. Indeed, GFPs can be visualized at every stage of animal development. Embryonic
and primary celis obtained from tissues expressing fluorescence could be cultured and the
fluorescence viewed microscopicaily to determine intracellular protein localization, or
used in FACS analyses.
Thus, the transgenic approach, when coupied with GFP technologies, can be an
extremely practical and powerful tool for genetic studies.
1.3.4. Genetically Engineering the Mouse Genome to Study Genes Involved in
the Response to Oxidative Stress
Mouse studies have been useffil in shaping our understanding of the biological
functions of specific genes involved in the response to oxidative stress. For instance, a
mouse model for familial amyotrophic lateral sclerosis (ALS) in which mice bear
mutations on the SOD1 gene was developed. These animais were found to exhibit
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enhanced oxyradical production and lipid peroxidation, as well as several other typical
features of oxidative stress (Kruman et al., 1999). Another report shows that SOD2-
deficient mice have increased levels of DNA damage and incidences of cancer (Van
Remmen et aÏ., 2003). Kim et al. (2004) demonstrated that transgenic mice that
overexpress the Sodi protein have increased resistance to oxidative stress induced by
kainic acid. These examples highlight how manipulating specific genes provides insight
into the genetics and biology ofdisease at the level ofthe entire organism.
Unfortunately, this direct link between gene and health is much less evident in
studies examining genes involved in the Base Excision Repair pathway. For instance,
Oggi is a DNA glycosylase, which removes the oxidative lesion $-oxoG in the early
steps of this repair pathway. It was hypothesized that mice lacldng this important
glycosylase would accumulate damaged bases and mutations, and therefore, be at a
significantly higher risk for free-radical-induced pathology. Surprisingly, OGG1 mice
exhibited an increase in lesion frequency, but showed no noticeable health problems
(Kiungland et al., 1999, Minowa et al., 2000). Indeed, the phenotype ofhypermutability,
with no accompanying increase in disease, was observed in other mouse studies involving
targeted knockouts of other DNA glycosylases such as ailcyladenine glyocosyïase (Bevin
et al., 1997) and Nthl (Cunningham et al., 2002). Similarly, mice deficient for the DNA
polymerase f3, the polymerase responsible for fihling the gap lefi by the endonuclease
upon excision of the damaged base, exhibit an accumulation of DNA damage whule
lacking any noticeable increase in pathological conditions (Cabelof et al., 2002). Thus, it
appears that BER proteins have considerably redundant functions.
Further, other repair mechanisms are also involved in attenuating the effects of
a deficiency in BER genes. For example, the Cockayne syndrome B (CSB) protein is
typically associated with both transcription-coupled (TCNER) (Le Page et al., 2000) and
global (GNER) Nucleotide Excision Repair pathways (Sunesen et al., 2002). However,
OGGF’7CSW’ mice accumulate more premutagenic 8-oxoG lesions than either OGG1
or CSW mice (Osterod et al., 2002), indicating that CSB protein functions in repafring
oxidative lesions, albeit to a lesser extent in comparison to OGGÏ.
Interestingly, although genetic studies in mice have flot been successful in
establishing a direct correlation between gene and pathology, epidemiological studies in
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humans suggest that disruption of ffie BER pathway may increase susceptibility to
disease. For example, one noteworthy study indicates that individuals who have low
levels of Oggi are at increased risk to lung cancer (Paz-Elizur et al. 20003).
In sum, the relationship between the repafr of oxidative DNA damage and
health is complex. As more animal studies are performed, the relative role played by
individual genes, and how these genes act in concert to prevent, cause or increase
susceptibility to diseases, can be better assessed.
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1.4. Rationale
Although vital, oxygen molecules pose a permanent threat to aerobic ceils. When
metabolized into free radicals, these can cause significant damage to essential cellular
components, including DNA. Generated as by-products of natural biological processes
and as the resuit of exposure to various exogenous agents, including the UVA component
of solar irradiation, exposure to reactive oxygen species is continuous and unavoidable.
Ceils have consequently developed complex prevention mechanisms and DNA repair
networks to cope with this paradoxical situation. However, if these mechanisms fail,
organisms are at increased risk to oxidative damage and mutagenesis. Jndeed, a number
of conditions and diseases are associated with oxidative stress.
The RRD1/PTPA gene was found to play an important role in the cellular
response to oxidative stress in yeast. Although it appears to have several distinct
functions, several unes of evidence corroborate Ptpa’s putative role in mediating the
response to oxidative DNA damage. Further, several features of the PIPA gene suggest
it is involved in pathways related to carcinogenesis. Our laboratories aspfred to elucidate
this gene’s precise function in the cellular response to oxidative stress and to determine
how altering it may affect mammalian health. Genetically manipulated mice are
powerful tools to illuminate the function of specific genes and their contribution to
overail health. Therefore, we sought to generate two types of genetically manipulated
mice to study PIPA: conditional knockout mice, in which this gene could be temporally
or spatially disnipted, and transgenic mice that would, express Ptpa ffised to a GFP in
addition to the endogenous levels of Ptpa protein.
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2. Materials and methods
2.1. Cloning Techniques
2.1.1. Preparation of Competent Celis for Cloning
b prepare competent E. cou DHS-Œ celis, a small amount ofbacteria was scraped
from the frozen stock and allowed to grow in 5mL LB medium with 6mM MgSO4 at
37°C for approximately 18 hours. The 5mL of culture was subsequently added to 200
mL of LB containing 6mM MgSO4. This larger culture was again incubated at 37°C until
the optical density was established to be between 480 nm and 550 nm. When this density
was reached, the bacteria was alÏowed to cool on ice for 5 minutes, afler which they were
placed in 5OmL falcon tubes and centrifuged at low speed (4000 rpm) at 4°C for 20
minutes. Resulting bacterial pellets were obtained and re-suspended in 2OmL of TFB I,
incubated on ice for 10 minutes, and centrifuged again at low speed (4000 rpm) at 4°C
for 10 minutes. The bacterial pellet was re-suspended in 2mL cold 1FB II, aliquoted in
sterile eppendorf tubes (200 i.iL/tube) and stored at -80°C. One tube of prepared
competent E. cou was used for one transformation.
2.1.2 Transformation of Competent Celis with Plasmid DNA
An aliquot of competent bacteria was placed on ice for five minutes. Ligated
DNA fragments or a circularized plasmid were added to the bacteria and lefi on ice for an
additional 30 minutes. The bacteria were then incubated at 42°C for 90 seconds, afier
which lmL of LB was added. The celis were allowed to recover from the heat shock and
to begin expressing the antibiotic resistance gene for one hour at 37°C , afier which they
were plated on LB agar plates containing 0.1 mg!ml of ampicillin and or 0.5 mg/ml
kanamycin (depending on the plasmid) and incubated for 16 - 24 hours at 3 7°C.
2.1.3. Mini-and Maxi-Preparation Methods for Plasmid Purification
Bacterial colonies were picked and inoculated in 3mL of LB medium for 16 - 24
hours at 3 7°C. $mall scale plasmid purification (1 .5mL bacterial culture) was performed
as described by Bimboim and Doly (1979). Larger scale purifications (50 - 500mL of
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bacterial culture) were performed using the same ratio of solutions. Protein contaminants
were eliminated by standard phenollchloroform extractions.
2.1.4. Restriction Digestions and DNA Modification for Clonïng
Afler the plasmid purification, the DNA was digested with restriction enzymes
that would enable us to determine if the desired construct was indeed obtained. Usually,
for plasmid verification, approximately 250 - 500ng were digested with the appropriate
restriction enzymes for 1 - 4 hours with 5 units of the appropriate enzyme and buffer
dilution in a total volume ranging from 15 to 2OjiL, and ifien placed at the appropriate
temperature (usually 37°C). Larger scale restriction digestions were performed when the
DNA was to be used for cloning purposes; up to l0jig of DNA was used, with 20 units of
enzyme and the appropriate buffer dilution in a total reaction volume ranging from 20 to
4OjiL.
When a vector plasmid was linearized with compatible ends, digested DNA was
treated with 5 units of Calf Intestinal Ailcaline Phosphatase (ClAP) (Promega) for 45
minutes. The ClAP supplied by Promega is sufficiently versatile to work in virtually all
restriction digestion buffers, and was therefore added dfrectly to the restriction digestion
reaction.
Although restriction digestion was routinely used as a method of confirming that
the appropriate clone was obtained, the integrity of loxP sites, s as well as certain clones
were confwmed by automated sequencing using the Research Center’s ABI PRISM 3100
Genetic Analyzer (Applied Biosystems), following the manufacturer’s protocols and
procedures.
2.1.5. Polymerase Chain Reaction to Generated Clonable Fragments
The Polymerase Chain Reaction (PCR) was used to amplify fragments, thereby
enabling the engineering of convenient restriction sites for cloning. Typically, the
program consisted of 30 cycles, each consisting of a denaturing step (95°C for 1 minute),
an annealing step (52°C for 1 minute), an elongation step (72°C for 2 minutes/kb to be
amplified), and a fmal long elongation step (72°C for 10 minutes). PCR reactions were
performed in appropriate reaction buffer dilution (buffer supplied with the enzyme) with
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3mM MgSO4, 1 jig of each oligonucleotide, 0.5rnM of each dNTP, 25 - 1 OOng of template
DNA with 1 - 3 units of Pfu polymerase in a total volume of 1 00tL The Pfu was used
because it possesses a proofreading activity, decreasing the chance of errors taldng place
during the amplification process.
2.1.6. Fragment Purification for Cloning
Fragments obtained by restriction digestion were resolved and observed on
ethidium bromide-stained 1% agarose gels. The specific fragments to be used for cloning
were physically removed from the gel using a blade, and purified using Amersham GFX
Gel Purification Kit.
2.1.7. Ligation Reactions for Clonïng of DNA Fragments
Relative concentrations of purified DNA fragment were estimated visually on an
agarose gel. To maximize cloning efficiency, three ligations were usually performed,
each with varying vector:insert ratios ranging from molar ratios of 1:2 to 1:10. Ligations
were performed in volumes ranging from lO1iL to 151.tL, using 10 units of Promega or
New England Biolabs ligase and the appropriate buffer dilution. The duration and
temperature of incubation varied from 1 hour ligation reactions at room temperature, to
16 - 24 hour ligation reactions at 16°C.
2.1.8. General Clonïng Strategies
Three strategies were used for the creation of the various constructs. The first was
the standard plasmid digestion and fragment purification followed by ligation and
transformation in competent bacteria. The second strategy involved amplifying
fragments of DNA using specially designed primers to engineer restriction sites for
cloning andlor other short sequence within the amplified product. Afler the PCR
reaction, the amplified DNA could simply be restriction-digested, purified and ligated as
in the first strategy. The third strategy differs from the others in various respects: no
phosphatase treatment was performed on linearized plasmids, and fragments were not
purffied from agarose gels. Instead, this type of cloning was performed on large
fragments that could flot easily be resolved from undigested, supercoiled plasmid on
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agarose gel or when only one restriction site was available for cloning in the DNA
sequences to be ligated. Thus, plasmids were restriction-digested with a single enzyme,
ethanol-precipitated and ligated directly. This method could only be performed when the
plasmids carried different resistance genes (ampicillin and kanamycin). Therefore, only
constructs containing both plasmids could grow in media containing both antibiotics.
The enrichment of positive clones by double selection compensated for the increased
chance of obtaining undigested or religated plasmids due to the fact the DNA was flot gel
purffied or treated by ClAP.
2.2. Generating Iransgenic Mice
2.2.1. Micorinjection of the Oocyte and Breeding Procedures
The DNA construct microinjected into mouse oocytes was prepared by other
members of the laboratory and subsequently implanted in pseudo-pregnant females. The
microinjection of the linearized DNA construct into fertilized mouse oocytes and the
transfer to pseudo-pregnant females was performed by the Animal facility of the
Recherche Guy-Bemier Research Centre according to the protocols approved by the
Centre’s Committee for Animal Protection. The pseudo-pregnant females carried these
fertilized oocytes to terni. Pups were bom three weeks afier the microinjection and
thereafier weaned and crossed with fertile mice CD-l males or females. The pups
resulting from this second cross were weaned and screened for transgene integration at
the age of 3 weeks or older. When a mouse was established as transgenic, it was crossed
with a transgenic sibling, when possible, or with a CD-l mouse. Thus, independent
families of transgenic mouse mes were generated. Mice were routinely weaned at the
age of three weeks. All matings and screening procedures were performed when mice
were at least three weeks of age.
2.2.2 Screening for Transgenic Mice
2.2.2.1. Extraction of Mouse Tau Genomic DNA
Southem blotting is the method of choice for reliable detection of transgene
integration. Screenings were performed on DNA purified from mouse tau clippings.
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Approximately 1 cm of tau was cut from the mice, digested in Tau Mix for 4 - 16 hours
and purified by gentie mixing, first with phenol and then with chloroform, for a period of
five minutes. This mixture was centrifuged at 12,000 X g for 5 minutes, aCter which the
supematant containing the DNA was transfeffed to an eppendorf tube containing 1 mL of
100% ethanol, incubated at -80°C for 10 minutes and centrifuged at 12,000 X g for 10
minutes. Following the ethanol-precipitation, DNA was washed with 70% ethanol and
resuspended in water containing approximately 20 ng!mL of RNAse A. The
concentration ofthe DNA was obtained using the spectrometer.
2.2.2.2. Restriction-Digestion and Treatment of Genomic DNA for Southern Blofting
Approximately 1 5tg of genomic DNA were restriction-digested with 50 units of
BamHI for 6 - 16 hours. The digested DNA was run on a 1% agarose gel until the DNA
was sufficiently resolved as visualized by ethidium bromide staining and exposition to
UV light. The agarose gel was placed in a depurination buffer for ten minutes, afier
which the agarose gel was soaked twice for 30 minutes, first with denaturing and then
with neutralizing solutions.
2.2.2.3. Transfer of DNA to the Nitrocellulose Membrane
A reservoir containing 20 X SSC was prepared, in which two agarose gel-sized
Whatman filters and one gel-sized Hybond N nitrocellulose membrane (Amersham)
were soaked. An elevated surface was placed within the reseiwoir, upon which lied a
large strip of Whatman paper, extending on two parallel ends into the SSC buffer. The
treated agarose gel was place upside down on this elevated Whatman paper. The pre
wetted nitocellulose membrane and the two Whatman filters were place on the membrane
and air bubbles were removed. The sides of the agarose gel were sealed and the reservoir
covered with saran wrap. Approximately three inches of paper towel were placed on top
ofthe filters, upon which was placed a weight of approximately 500g.
The DNA transfer onto the nitrocellulose membrane was allowed to take place
ovemight. The DNA was fixed to the membrane by exposing the membrane to UV for
one minute.
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2.2.2.4. Preparation of the Radioactive Probe
The vector used for microinjection in the mouse blastocyst, cPIPA-EYFP, was
restriction-digested with NotI and BamHI. This digestion yieids two fragments;
including the 1 .5kb fragment corresponding to the PIPA and EYFP sequences. This
fragment was purified from the gel as described in section 2.1.6. Approximately 5Ong of
the purified fragment were denatured at 95°C for 3 minutes, placed on ice for 2 minutes
and labelled with radioactive dCTP using Ready-To-Go DNA Labelling Beads (-dCTP)
(Amersham). Briefly, the kit supplies a pre-dispensed reaction mix in bead form. The
bead containing a Klenow fragment is activated upon the addition of the radioactive
dCTP and the denatured DNA. Afier the 15 minute labelling reaction, the }Uenow
fragment was inactivated by adding 2pL of 0.5 M EDTA, as recommended by the
manufacture. The unincorporated radioactive dCTP was removed using ProbeQuant G-50
micro columns (Amersham) following the supplier’s protocol.
2.2.2.5. Hybridization of Radioactive Probe to DNA on Nitrocellulose Membrane
The membrane was transferred to a hybridization bottie. Approximately lOmL of
ULTRAhyb Ultrasensitive Hybridization Buffer (Ambion) were added to the bottle for a
two hofur pre-hybridization treatment. The radioactive probe was denatured at 95°C for 3
minutes, placed on ice for 2 minutes and added to the bottie containing the membrane and
ULTRAhyb buffer. The probe was allowed to hybridize with the genomic DNA
ovemight at 42°C, as recommended by the UltraHyb manufacturer.
2.2.2.6. Membrane Washes and Exposition
Afler the completion of the hybridization step, the membrane was quickly washed
with wash solution I. b remove non-specific hybridization, additional 20-minute washes
were performed; three with wash solution II, and three with wash solution III. Ail washes
were carried out at 65°C. Membranes were exposed with a film at -20°C using two
intensifying screens for a minimum of 36 hours. More stringent washes or longer
expositions were performed depending on the intensity of the signal and on the level of
background.
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2.2.3. Dissections ami Preservation of Individual Organs for Protein
Extractions
In order to verify if the transgene was expressed, animais were sacrificed and
different tissues stored for protein analysis. Mice were sacrificed by the Animal Facility
staff. Dissections were performed and individual organs were immediately frozen in
liquid nitrogen. Afier this initial freeze, they were placed in screw cap tubes, which were
kept immersed in the liquid nitrogen. The kidneys, liver, heart, lungs, spleen, pancreas,
intestine and skin tissue were obtained and stored at -80°C. For protein extractions,
approximately 1 OOng of tissue and 1 OOpL of Protein Extraction Buffer were placed in a
Potter—Elvehjem glass homogenizer on ice. The tissue was cmshed on ice until there
were no discernable pieces of the organ left. The resulting mixture was then transferred
to a sterile eppendorf tube and was centriftiged at 10,000 X g for 10 minutes at 16°C.
The supematant was removed and the concentration was estimated using the Bradford
assay (Bradford, 1976). Protein extracts were aiways maintained on ice.
2.2.4. Western bloffing
2.2.4.1. Protein SDS-PAGE Electrophoresis
Tissue proteins were resolved on 10% $DS-Page gel. The resolving portion of
the gel was poured into the mould and the upper layer levelled by quickly covering it
with ethanol. The gel was allowed to polymerize for at least 20 minutes. During this
time, the stacldng gel was prepared. Once the resolving portion of the gel was
polymerized, the ethanol was replaced with stacking gel and the comb adjusted to the
apparatus. Upon polymerization, the entfre gel was placed in the electrophoresis cast and
iL of iX migration buffer was added. Approximately 50jig of protein were loaded per
well ofthe $DS-PAGE for a period of 90 minutes at 120V.
2.2.4.2. Transfer of Proteins to the Nitrocellulose Membrane
Before proceeding with the transfer, the gel, a Hybond ECL membrane and four
3MM Whatman filters cut to match the size of the gel were soaked in transfer buffer for
15 minutes. The transfer was set up by placing the membrane facing immediately the gel.
Two Whatman papers were placed facing the other side of the membrane and gel. The
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stack of gel and membrane sandwiched by Whatman filters was placed in the transfer
apparatus, to which 1 L of transfer buffer was added. The apparatus was transferred to a
cold room and was placed in an ice reservoir to prevent overheating. The transfer was
typically performed for 1 hour at 100V. Protein transfer was confirmed by colouring the
membrane with Ponceau S.
2.2.4.3. Membrane B]ocking, Bloffing and Exposure
The membrane was saturated for 30 minutes at 37°C (or ovemight at 4°C) in
TBST with 5% skim millc. The membrane was then washed twice with TBST for a
period of 5 minutes. The primary antibody was prepared by adding antibody to 2% millc
in TBST (1/1000 dilution for PTPA-specific antibody, a gifi from Dr. Egon Ogris, or
1/5000 for Clontech’s GFP-specific antibody). The membrane was incubated with the
PTPA antibody at 4°C ovemight or with the GFP antibody at room temperature for 1
hour. This incubation period was followed by two additional 5 minute TBST washes.
Subsequently, the membrane was incubated with ifie secondary antibody (mouse anti-IgG
with peroxydase for the GFP antibody, and rabbit anti-IgG with peroxydase for the PTPA
antibody), diluted 1/1000 in 2% milk dissolved in TBST for 1 hour. This was followed
by four additional 5 minute TBST washes.
During the last wash, equal volumes of the detection solutions 1 and 2 of the
Amersham ECL kit were mixed together. The total volume of ECL mix was of 0,125
mL/cm2 of membrane. Afier the fmal wash, the membrane was sponged dry, covered
with the ECL mix and incubated at room temperature for 1 minute. Excess liquid was
removed from the membrane with a Whatman filter. The membrane was then enveloped
in Saran wrap, placed in a cassette and exposed to a film for various times ranging from
one second to 2 minutes before exposure.
2.2.5. Macroscopic EYFP Detection
Many systems allow for the macroscopic visualization of EYFP in mice. Indeed,
certain companies can provide equipment that is sufficiently sensitive to detect
fluorescence through the mouse skin. Therefore, dissections need flot be performed to
visualize fluorescence ofmouse inner organs.
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These GFP visualization devices essentially consist of a bright light equipped with two
filters: one that limits the wavelengths that will reach the fluorescent animal (the
excitation fiiter), and one that limits the wavelengths that are viewed by the experimenter
(the emission filter). However, most of these systems are rather costly and require many
accessories. Our laboratories empioyed a more cost effective system that allows for
macroscopic assessment for fluorescence in live and recently sacrificed mice, namely the
Clare Chemicai Dark Reader Spot Lamp. This lamp is equipped with an excitation fiiter
that ailows wavelengths between 400nm and 520nm. In addition, viewing goggies
consisting of emission filters that allow oniy wavelengths over 540nm to pass through
were also used. This combination of excitation and emission wavelengths is appropriate
for viewing ofEYFP (EYFP Ex Max = 513nm; Em Max = 517nm). However, the major
setback of this system is that it does not corne equipped with cameras or with filters that
can be adjusted to standard photographic equiprnent. In addition, the light source is not
sufficiently strong to detect fluorescence through mouse skin. As such, GFP detection of
inner organs can only be perforrned if dissections are carried out and individual organs
are exposed to the filtered light and observed with the viewing goggles. This is
especially disadvantageous when fluorescence is being used as a method to screen
animais, because to identif’ transgenic mice, the mice must be sacrificed and are
therefore de facto exciuded from further study. Stili, although the Spot cannot detect
fluorescence on inner organs, EYFP should be observable on hairless tissue such as ears
and feet or on hairless pups less than ten days of age.
2.6. Media, Buffers, Antibiotics and Solutions
2.6.1. Media
LB (Luria Bertani) medium
Bacto tryptone, 10g; bacto yeast extract, 5g; NaC1, 10g; dissolved in iL distilled water.
LB agar soiid medium
Bacto tryptone, 1 0g; bacto yeast extract, 5g; NaCi, 10g; agar, 6g; dissolved in 1 L distiiled
water.
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2.6.2. Antibiofics
Ampicillin, 1 g; dissolved in 10 mL distilled water, sterilized by filtration.
Kanamycin, 0.5 g; dissolved in 10 mL distilled water, sterilized by filtration.
2.6.3. Oligonucleotides Used as Primers for PCR Reactions
The primers were sometimes designed to engineer new restriction sites (underlined), or
other sequences, such as loxP (in italics). Wben possible, the primer was almost entfrely
complementary to the template sequence, modifying as few bases as possible to
maximize amplification efficiency. Otherwise, the entfre restriction sequence was added
to the extremity of the primer.
Oligonucleotide Sequence Composition Application
F1-mPTPA-UP GCTTGATATCGAAUCGG Template Cloning loxP site
ATCC I I I I C1T sequence in pCSI
R1-mPTPA- CCATGCTaqatctATAACTTC Bglll, Ioxp, Cloning IoxP site
BglII-LoxP GTATAATGTATGCTTACGA template in pCSI
A G TTA TAGTAACAAATGAG seq uences
TCCTTGCC
F4-PGKNeo- GCTAGCGAAUCGCTAGC EcoRi, NheI, Cloning PGKNeo
Ecorl-NheI GGTGGCGGCCGMGUC template in pCS2 plasmid
CTAHCT sequences
R4-PGKNeo- GCTAGCCTCGAGGCTAGC Nhel, Xhol, Cloning PGKNeo
XhoI-RI-NheI ATAACUCGTATAATGTAT template in pCS2 plasmid
GCTAT sequence
T3 Primer TTAAUGGGAGTGATCC pSK sequence Sequencing
C pCS1
T7 primer GTAATACGACTCACTATA pSK sequence Sequencing
GGGC
Table 1. Oligonucleotide primers used for PCR amplification of fragments for cloning or for
verifying orientation of ligated fragments. F — sense primer; R — antisens primer.
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2.6.4. Buffers
5OXTAE
Tris base, 242g; Glacial Acetic Acid, 57.lmL; EDTA, 18.6g; distilled FT2O water,
completed to 1 L.
Resolving gel buffer
Tris Base: 18.17 g; $DS 0.4 g ; completed with distilled water to 100 mL; pH adjusted to
8.8withHCl
Stacking gel buffer
Tris Base, 6.06g; SDS, 0.4g ; completed with distilled water to lOOmL; pH adjusted to
6.8 with HC1.
5X Migration Buffer for SDS-PAGE
Tris-base, 15.lg; Glycine, 94g; SDS 20% 25mL; distilled water, completed to iL.
Transfer buffer for Western Blot
Tris-base, 9.lg; glycine, 43.2g; methanol 100% 600mL; SDS 20% 7.5 mL; distilled
water, completed to 3L.
Tau Mix
lOmM Tris, pH= 8.0; 5mM EDTA; 1% SDS; 0.3M NaOAc ;200 ig!ml Proteinase K.
Protein Extraction Buffer
25mM Hepes (pHz7.4); 150 mM NaC1; 1mIvIATP; 3mMMgC12;0.2mM
phenylmethylsulfonyl fluoride; 1 g/ml aprotinin; 10 g/ml leupeptine; 10 g!ml pepstatine.
2.6.5. Solutions
Agarose
5g dissolved in 500mL TAE 50X.
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1FB I
3OmM KOAc; lOmM Cacl22H2O; 5OmM MnCl24H2O; lOOmM KC1, 15% (v/v)
glycerol-water.
1FB II
lOmM MOP$; 75mM CaC122H2O; lOmM KC1, 15 % v/v glycerol-water.
Mini-prepare solutïons
Solution I: 5OmM glucose; 25mM-Tris-HC1; lOmM EDTA; pH adjusted to 8.0 with
HC1.
Solution II: 0.2M NaOH, 1% $D$.
Solution III: 3M KoAC; 2 M CH3COOH glacial.
Depurination solution
HC1, 21 .4mL;completed with distilled water to 1 L.
Denaturing solution
NaCI, 175.32g; NaOH: 40g; completed with distiÏled water to 2L.
Neutralizing solution
Tris-HC1, 121.1 4g ; NaC1, 175 .32g ; completed with distilled water to 2L; pH adjusted to
7.0.
20X SSC Solution
NaC1, 175.3g; Sodium citrate, 882g, completed with distilled water to iL; pH adjusted to
7.0.
Wash solutions L II, III
2X SSC, 0.1% SDS; 1X SSC, 0.1% SDS; 0.1X SSC, 0.1% SD$, respectively.
10 % Resolving Gel for SDS-PAGE
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Acrylamide (29:1), 3.35mL; resolving gel buffer, 2.5mL; ammonium persulfate 10%
100L; distilled water, completed to lOmL; TEMED, 10 jiL.
$tacking Buffer 5 %
Acrylamide (29:1), 1 .4mL; stacking gel buffer, 1 .3mL; ammonium persulfate 10%
100J.1L; distilled water, completed to lOmL; TEMED, lOjiL
TBST
Tris-HC1, 1M, pH 8.0: 2OmL; NaC1 5M, 30 mL; Tween 20%, 5mL; completed with
distilled water to iL.
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3. Resuits
3.1. Cloning of PTPA-Neo-loxP
3.1.1. General Cloning Considerations
Ihe design and cloning of the targeting vector is complex and invoïves several
plasmids. Generally, our strategy involved creating three independent vectors: pCS7,
pCS8 and pCS9. Fragments from these plasmids could be cloned to obtain the final
vector, pCS1O, in the future.
Briefly, the mouse PIPA gene is composed of 10 exons. Our laboratories have
previously isolated exons 5 - 10, which span approximately 10 kb. DNA of this length
can be difficuit to manipulate in cloning applications. Therefore, the first constructs were
designed to isolate a smaller, more workable PIPA fragment. We constmcted plasmids
pCS and pCS1 to isolate 4.7 kb ofthe 5’ end ofthe 5 - 10 exon portion ofthe gene. We
then integrated the first loxP site in pCS 1, 5’ of exon 6 (jCS2), and subsequently, an frt
PGKNeo-frt-loxP cassette (for positive selection), 3’ ofexon 7 (pCS4).
Two other plasmids were prepared parallel with these cloning steps. The aim of
constructing pCS7 was to modify a PGKPuro cassette (for negative selection) for future
cloning into pCS4. pCS9 was designed to allow us to subclone a portion of the PIPA
gene that could later be inserted into this pCS7 plasmid. Ihus, this step would lengthen
the sequence of the 3’ end of the PIPA gene, forming the final clone, pCS1O. Upon
linearization with XhoI, this construct could 5e used for gene targeting in ES celis. Ibis
fmal clone bas not yet been completed.
Ihe cloning strategy involves ten different vectors. A schematic representation of
each procedure is included to help conceptualize the cloning design. In these illustrations
only selected restriction sites are shown, and can be used as landmarks. Ihe position of
the restriction sites is included as an additional reference point and for restriction
digestion analysis. Ihe portion of a given plasmid that was sub-cloned is outlined with a
black line within its parent plasmid. When cloning was performed using an amplified
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DNA fragment, the template plasmid as well as the amplified product are illustrated.
Every individual plasmid is drawn to scale with respect to its various regions and
components. However, due to the variable sizes of plasmids, ranging from 3 - 18 kb,
these were flot illustrated to scale with respect to each other.
Most clones were identified by performing restriction digestions of candidate
plasmids isolated from bacterial colonies. Extensive restriction analysis was generally
carried out to confirm the authenticity of a clone. For simplicity, only a subset of this
analysis appears in the figures presented here. The restriction digestions presented in the
figures were selected because ffiey clearly demonstrate that a correct clone, in which the
insert has been incorporated in the appropriate orientation, has been obtained. In some
instances, restriction digestion of plasmids was not sufficient to confirm that the correct
clone was obtained. In these cases, plasmid DNA was sequenced.
3.1.2. Cloning ofpCS
The first cloning step consisted of removing approximately 3 kb from the 3’ end
of the genomic PTPA sequence. Digestion of pPTPA with SmaI yields bands of
approximately 10 and 3 kb. The 10.8 kb band, consisting ofthe 5’ end 8 kb ofthe PTPA
fragment and the pSK vector, was isolated and ligated to form pCS (figure 5).
A number of restriction digestions demonstrate that the correct clone was obtained
(Figure 5B). As expected, pC$ is linearized to approximately 10 kb when digested with
SmaI (lane 3). When pC$ is digested with $acl (lane 4), bands of 2.1, 2.6, 2.9 and 3.2kb
are observed. The deleted sequence contained several SacI site. Had the 3’ end not been
deleted, additional bands of 0.58, 1.5, 2.3, 3.3kb would have been observed. Finally,
digestion with NheI (lane 5) is also consistent only with the expected pCS clone. A 1.8
kb fragment occurs upon NheI digestion of both pPTPA and pCS, but the second
fragment of 9kb is consistent with loss ofthe PTPA 3 kb 3’ fragment to form pC$.
The faint band observed above the 9kb fragment upon digestion with NheI
represents undigested DNA. Partial digestion of plasmid can occur for several reasons:
loss of restriction enzyme activity, suboptimal buffer conditions, or the presence of
impurities in plasmid DNA. The buffer used for this digestion was provided by ifie
enzyme manufacturer and was routinely used in the laboratory without difficulty, and
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SmaI and SacI enzymes have fully digested the plasmid DNA, indicating that it was free
of digestion-inhibiting impurities. Therefore, it seems more likely that this unexpected
hand resulted from enzyme activity loss rather than suboptimal buffer conditions or the
impurity of plasmid DNA.
Figure 5: Cloning of pCS. A. Schematic representation of the clone. B.
Agarose gel indicating that the pCS clone was obtained (Lane 1, 1 kb ladder;
Lane 2, pCS undigested; Lane 3, pCS digested with SmaI; Lane 4, pCS
digested with Sac I; Lane 5, pCS5 digested with NheI).
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3.1.3. Cloning ofpCSl
The goal of the next cloning step was to further shorten the PTPA fragment. A
4.7 kb fragment consisting of exons 5
- 7 was generated by digesting pCS with ApaI.
Ihis fragment was cloned into the ApaI-linearized pSK (Strategene’s Bluescript vector).
Two orientations were obtained, of which one (pCS1) was retained for subsequent
cloning steps. Ihus, the pCS1 vector consists of 4.7 kb of the 5’ end of the PIPA gene
within a pSK (figure 6).
Generation of uncontaminated insert posed a significant difficulty in producing
this clone. Indeed, digesting pCS with ApaI generates several fragments of different
sizes, including one fragment of 5.4 kb, corresponding to the sequence between the ApaI
sites at positions 6,012 and 667 ofpCS. Despite running the digested pCS vector on the
agarose gel for an extended period oftime, the 5.4 kb and the desfred 4.7 kb fragments
migrated in close proximity to one another. This made it difficult to physically isolate the
correct hand without contamination from ifie larger fragment.
Digestion with ApaI (figure 6B) and Kpn (figure 6C) indicates that the desired
fragment was inserted in the pSK vector. As expected, the ApaI digestion generates 2.9
kb and 4.7 kb hands. Had the 5.4 kb contaminant been inserted in the linearized vector,
the digestion would have generated 2.9 and 5.4 kb hands. This is consistent with the
KpnI digestion, which yields a single fragment below the 8 kb marker band. Had the
incorrect insert been incorporated, the linearized fragment would have migrated to above
this band, to approximately 8.4 kb.
These digestions did flot provide information about the orientation of the plasmid,
nor do they prove conclusively that the correct fragment was ligated to the vector. This
uncertainty led us to seek a way to confirm the authenticity of this clone rapidly and
frreffitably. Therefore, the candidate pCSl plasmid was sequenced using the 13 primer,
Figure 6: Cloning of pC$ 1. A., Schematic representation of the clone. B.
Agarose gel indicating the pCS1 clone was obtained (Lane 1, 1 kb ladder;
Lane 2, undigested pCS1; Lane 3, pCS1 digested with ApaI) C. Agarose gel
indicating the pCS1 clone was obtained (Lane 1, pCS1 digested with KpnI;
Lane 2, undigested pCS 1; Lane 3, 1 kb DNA ladder).
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which provides the sequence 5’ of the NotI site (2,2 17), into the PTPA gene. The
sequence obtained was consistent with the expected plasmid as presented in Figure 6.
3.1.4. Cloning of pCS2
We sought to incorporate a loxP site 5’ of exon 6, at the position of BamHI
(4,495) of pC$1. b do this, a 2.2kb portion on the 5’ end the PTPA gene pC$1 was
amplified using pCSl as a template. Oligonucleotide primers were designed to include
the loxP sequence and restriction sites to facilitate cloning. The sense primer, Fi
mPTPA-UP, consisted of sequence complementary to the PTPA gene, and the anti-sense
primer, mPTPA-BglII-loxP, contained the 34 hp-long loxP sequence, a BglII site for
cloning, and the PTPA-complementary sequence. b obtain pCS2, the amplified PCR
product was digested with BamHI and BglII, and ligated with the 5.5 kb fragment from
BamHI-digested pCS 1. BamHI and BglII generate compatible ends. However, ligation
ofthese ends disrupts both ofthese sites (Figure 7).
Initially, pC$2 was confirmed by restriction digestion analysis. Figures 7B and 7C
indicate that the insert was integrated in the vector in the expected orientation. Digestion
of pCS2 with BamHI linearizes the plasmid to approximately 7.7 kb (Figure 7B). This
would only be possible if one ofthe BamHI sites on the pC$1 plasmid had been disrupted
by ligation with a BglII end. The correct orientation is demonstrated by the digestion of
pCS2 with SacI, which generates 2.1 and 4.6 kb bands (Figure 7C). Had the insert been
incorporated in the opposite orientation, the SacI sites would have been within 50 bp
from each other, yielding bands of 7.6 kb and 50 bp. In addition to the 2.1 and 4.6 kb
hands obtained upon SacI digestion, a faint hand of approximately 9 kb can be ohserved
(Figure 7C). This corresponds to the same molecular weight as the undigested DNA
(Lane 2), indicating that ifie 9kb band represents plasmid which was not successfully
digested by the SacI enzyme (see section 3.1.2.).
Two aspects of this construct prompted us to sequence parts of the plasmid. First,
differences between pC$2 and pCS1 are minimal, making it difficult to distinguish them
exclusively on the basis of restriction digestion. Sequencing the vector would best
confirm the integration and orientation of the fragment. The T3 primer, which allows
I (6673)
teI
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sequencing 5’ of the NotI site (2,217), confirmed that the PCR product had been
incorporated in pCS 1 in the correct orientation.
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Figure 7: Cloning of pCS2. A., Schematic representation of the clone. B.
Agarose gel indicating the pCS2 clone was obtained (Lane 1, 1kb ladder;
Lane 2, pCS2 digested with BamHI). C. Agarose gel indicating the pCS2
clone was obtained (Lane 1, 1 kb ladder; Lane 2, pCS2 undigested; Lane 3,
pCS2 digested with SacI).
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In addition, it has been demonstrated the Cre recombinase can only mediate the
recombination between two identical loxP sequences (Chatterjee et al., 2004). Therefore,
we sought to confirm the integrity of the loxP site before proceeding further. We used
the Ri -mPTPA-BglII-loxP oligonucleotide to sequence the plasmid and demonstrated
that the loxP had flot been modifled during the amplification process. The primer
sequenced several bases past this site, providing further evidence that the correct clone
had been obtained.
3.1.5. Cloning of pCS4
Following the insertion of the first loxP site, the PGKNeo-loxP sequence was
inserted into pCS2 to form pCS4. To do this, the pK-1 1 plasmid, containing the PGKNeo
flanked by frt sites and a loxP site identical to the one designed in pCS2, was amplified
by PCR. The primers, (f4-PGKNe0-Ecorl-NheI and R4-PGKNeo-XhoI-RI-NheI), were
engineered such that the amplified product would have NheI sites in both extremities.
NheI-linearized pCS2 was ligated to the NheI-digested PCR product. Thus, the resulting
pCS4 plasmid contains the PGKNeo cassette flanked by frt sites, one loxP site located 3’
ofthe cassette (8,255), and one located 5’ ofexon 6 (4,419) (figure 8).
Several digestions allowed us to confirm that the PGKNeo-loxP was inserted in
the vector with the appropriate orientation (Figure 8B). Digesting pCS4 with NheI (lane
4) reconstituted the vector and insert used to construct the clone (2.2kb PGKNeo-loxP
vector, and 7.6kb pCS2 insert). The other digestions provide evidence that the correct
orientation was obtained. BamHI digestion (Lane 2) indicates bands of 3.8 and of 5.8 kb.
This is consistent only with fragment insertion with the correct orientation; incorrect
orientation would have generated fragments of 4.4 and 5.5 kb. Digestion with KpnI
generates the expected bands of 0.59 and 8.9 kb (Lane 3); the opposite orientation would
have produced 2.6 and 7.1 kb fragments.
Figure 8: Cloning of pCS4. A., Schematic representation of the clone. B.
Agarose gel indicating the pC$4 clone was obtained (Lane 1, undigested pCS4;
Lane 2, pCS4 digested with BamHI; Lane 3, pCS4 digested with KpnI; Lane 4,
pCS4 digested with NheI; Lane 5, 1 kb DNA ladder).
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We also sought to confirm the integrity of the loxP through sequencing the DNA
of the site. The 17 primer allows us to obtain the sequence immediately 5’ of the KpnI
site at position 8,927. The orientation of the insertion and the integrity of the loxP site
were also confirmed by this sequencing.
A smear appears in ail lanes, including Lane 5, which contains the 1 kb DNA
iadder. The ladder was used routinely and did flot usually produce smearing. This
suggests that this smear was flot the resuit of nuclease contamination from the DNA
samples or enzyme reaction mixtures. Rather, ifiis smear is probabiy the resuit of
migrating the agars gel at a high speed. Because the effects of this rapid migration are
uniform, the position of the bands relative to those in the 1kb ladder lane reflects the true
molecular weight ofthe fragments.
3.1.6. Cloning of pCS5
It has been hypothesized that recombination frequency of the targeting vector may
increase with the length of the homologous arms (see section 4.1.4.). The construction of
plasmids pCS, pCS1, pC$2 and pCS4 allowed us to incorporate the loxP, frt, and
neomycin sequences within the PTPA gene, leaving the 5’ and 3’ end arms of PTPA
homology of 4.1 kb and 610 bp, respectively. The aim of designing plasmids pCS5 and
pCS9 was to lengthen the 3’ arm. Two clones were required for this step because the
PIPA sequence that was intended to lengthen this arm of homology did flot contain
restriction sites that would aliow us to clone this fragment directly in pCS4. Therefore,
the specific goal in the construction of pC$5 was to engineer sites in the sequence of
homology to facilitate future cloning steps.
We produced pCS5 by ligating the 1.8 kb fragment obtained by digesting pCS
with NheI, with XbaI-linearized pBluescript (Figure 9). The NheI and XbaI digestions
generate compatible ends, which are disnipted when ligated.
A restriction digestion analysis indicates that the pC$5 has been obtained (figure
9B). The digestion of the construct with XhoI linearized the 4.7kb plasmid (lane 3). Had
the vector re-cfrcularized, this digestion would have generated a linearized 2.9 kb band.
XhoI and NcoI double digestion produced 3.6 and 1.1 kb hands, as expected (lane 4); the
incorrect orientation would have given 0.7 and 4.0 kb hands. This digestion also
12 3
• 4 j
“1
—2b
• 41kb
Figure 9: Cloning of pCS5. A. Schematic representation of the clone. B.
Agarose gel indicating the pCS5 clone was obtained (Lane 1, pC$5 digested with
NcoI and XhoT; Lane 2, pCS5 digested with XhoI; Lane 3, pCS5 undigested; Lane
4, 1 kb DNA ladder).
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generated a 4.7 kb fragment, representing linearized plasmid that was only digested at
one site. Given that digestion with XhoI alone was very effective (lane 3), and since this
double XhoLNcoI digestion was performed in a common buffer as recommended by the
manufacturer’s protocol, it would appear that this 4.7 kb band was generated because of
incomplete NcoI activity.
A smear appears in ail bands, including the 1kb DNA ladder, which was used
routinely in the laboratory without difficulty. As indicated earlier, this suggests that the
smear was caused by too rapid migration of the agarose gel rather than DNAse
contamination. This rapid migration lias little effect on the migration pattems of the
fragments. Therefore, the position of the bands in relation to ffie DMA ladder reflects the
true lengtli ofthese fragments.
3.1.7. Clonïng ofpCS9
The PTPA sequence in pCS5 is to be used in the fmal cloning step, aimed at
increasing the length the 3’ end of the gene in the targeting vector. This plasmid contains
an XhoI site, 3’ ofthe genomic sequence (position 669). However, it was anticipated that
the fmal construct, pC$ 10, would linearize with this enzyme. Therefore, we sought to
dismpt this site in pCS5, making the linearization ofpCSlO with XhoI possible. This was
achieved by digesting pCS5 with SalI and XhoI, enzymes generating compatible ends,
and re-circularizing the plasmid to form pCS9 (Figure 10). The ligation of these ends
disrupts both SalI and XhoI sites. With the XhoI destroyed, pCS9 could be used to
construct pCS 10.
As expected, XhoI and SalI digestion of pCS9 produced bands at the same
position as the undigested plasmid (Figure lOB, lane 2). Conversely, the digestion with
NcoI and XhoI linearized the plasmid the 4.7 kb plasmid. Had the plasmid not been
properly altered, the XhoJISalI and NcoJJXhoI digestions would have produced a 4.7 kb,
and 1.1 and 3.6 kb fragments, respectively.
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Figure 10: Cloning of pCS9. A., Schematic representation of the clone. B. Agarose
gel indicating the pC$9 clone was obtained (Lane 1, pCS9 undigested; Lane 2, pCS9
digested with XhoI and SalI; Lane 3, pCS9 digested with NcoI and XhoI; Lane 4; 1 kb
DNA Ladder).
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3.1.8. Cloning of pCS6
Iwo plasmids, pC$6 and pCS7, were designed in preparation for cloning the
PGKPuro cassette required for negative selection in ES celis, in either extremity of the
PIPA gene. These steps were required because of the absence of restriction sites that
would allow the direct integration ofPGKPuro in the pCS4 plasmid.
pCS6 was constructed by isolating the PGKPuro-Ampicillin fragment from the
BamHI-digested pEV-Puro plasmid, ligating it within the BglII-linearized EYFP plasmid
containing the kanamycin resistance gene (figure 11). Ibis allowed us to select bacteria
with resistance to both ampicillin and kanamycin, enriching for candidate plasmids that
contain both sequences to be ligated (see section 2.1.8). A number of clones containing
different copy numbers of PGKPuro-Ampicillin fragment in different orientations were
obtained. pC$6 was retained because it contained two copies of the PGKPuro cassette in
the same orientation. Ibis feature facilitated the following cloning step (see section
2.1.8.), in which the ampicillin resistance gene was disrupted.
Restriction analysis indicates that the plasmid retained for future constructions
contains the vector and two adjacent copies of the insert sequences in the same
orientation (figure 10). BamHI digestion of pCS6 generated hands of 3.6 and 7.8 kb
(Figure lOB). Had the plasmid contained less ifian two inserts, the resulting plasmid
would have generated a single band because of the disruption of one BamHI site by
ligation with the BglII-digested ends. Iherefore, this hand pattem eliminates the
possibility that only one copy ofPGKPuro-Amp was ligated into the pEYfP vector.
Ihe EcoRI fiirther demonstrates that two inserts in the same orientation were
integrated to form pC$6. Bands of 3.4 and 4.7 kb were obtained (lane 3), consistent with
the plasmid as presented in figure io. it is important to note that the 3.4 kb hand is
actually composed ofthe combined fragments oftwo identical PGKPuro sequences found
within an individual pÏasmid. Had the opposite orientation been obtained, fragments of
6.8 and 4.7 kb would have been observed.
Digestion with XhoI further confirms that pCS6 bas two copies of the insert in
same orientation. As expected, bands of 6.1, 3.4 and 1.9 kb were obtained (lane 4).
Only the construct as presented in Figure 1OA can account for this pattem.
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Figure 11: Cloning of pCS6. A., Schematic representation of the clone. B.
Agarose gel indicating the pCS6 clone was obtained (Lane 1, pCS6 undigested;
Lane 2, pCS6 digested with BamHI; Lane 3, pCS6 digested with EcoRT; Lane 4,
pCS6 digested with XhoI).
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3.1.8. Cloning ofpCS7
It was anticipated that future cloning steps would be difficuit because they
involved ligating large fragments. Since our strategy consisted of enriching for clones
containing vector and insert via double kanamycin!ampicillin selection, we sought to
disrupt the ampicillin gene in pCS6. The resulting construct, pCS7, would be resistant to
kanamycin only, enabling us to employ ffiis double selection strategy in future cloning
steps.
To restore pCS6 sensitivity to ampicillin, the plasmid was digested with blunt
end-generating XmnI and ScaI enzymes. In this plasmid, these sites are only located
within the ampicillin resistance gene. The 8.1 kb fragment isolated from this digestion,
which included the intact kanamycin resistance gene as well as the PGKPuro cassette,
was re-ligated. The resulting pCS7 plasmid therefore consisted of one copy of the
PGKPuro gene within the pEYFP vector and one copy of the truncated, non-functional,
ampicillin-resistance gene (Figure 12). Positive and negative selection with standard
doses of kanamycin and ampicillin allowed us to enrich for clones that had lost the gene
conferring resistance to the latter.
Restriction digestion analysis confirmed that the correct clone was obtained.
Digestion with XhoI generated bands of 1.8 and 6.5 kb (Figure 12B). Digestion with
EcoRI, and BamHI (Figure 12C) linearized the plasmid near the 8 kb band of the 1 kb
DNA ladder. These pattems are oniy consistent with the pCS7 plasmid as presented in
Figure 12A.
3.1.9. Clonîng ofpCS$
The three subsequent cloning steps consisted of piecing together the fragments of
interest from pCS4, pCS9 and pCS7. The pCS4 vector contains a portion of the PTPA
gene, the PGKNeo cassette, and the loxP and frt sites. The fmal element required for the
construct was the addition of the PGKPuro cassette for negative selection. Since no
restriction sites were available for the standard integration of PGKPuro within pCS4,
pCS$ was constructed by digesting pCS4 and pCS7 with NotI and then ligating the
linearized plasmids (Figure 13). $ince pCS7 confers resistance to kanamycin only and
54
XmiI (3)78) )TnVS
a3197)
B
7
6kbZ
2 kb—
15kb
2 3 4
Figure 12: Cloning of pCS7. A. Schematic representation of the clone pCS7 clone was
obtained (Lane 1, 1kb ladder; Lane 2, pCS7 undigested; pCS7 digested with XhoI). C.
Agarose gel indicating the pCS7 clone was obtained (Lane 1, 1 kb ladder; Lane 2, pCS7
undigested; Lane 3, pCS7 digested with EcoRI; Lane 4, pCS7 digested with BamHI).
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pCS9 confers resistance to ampicillin, the pCS8 ligation product was enriched for by
selection of bacteria resistant to both antibiotics.
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Restriction digestion analysis allowed us to determine wiffi greater certainty ffiat
the expected clone was obtained (Figure 1 3B). It is important to mention that in this
construct, the orientation of iigated fragments was of littie relevance. The presence of the
PGKPuro sequence is required for the purpose negative selection in ES ceils. Therefore,
ceils that have undergone homologous recombination would be expected to have
eliminated this sequence. We deveioped strategies to allow us to utilize ligated plasmids
in either ofthe possible orientations.
Digestion with NotI generates two bands of lengths equal to those of fragments
used to create pCS8, approximately $ and 10 kb (lane 4). As expected, digestion with
EcoRI generates fragments of 3.6 kb and approximately 14kb (lane 3), consistent with
clone as presented in Figure 13A. ApaI digestion (lane 2) generates bands of 7.5 and 10
kb, as expected for this orientation. Had the opposite orientation been obtained, this
digestion would have generated 3.6 and 13.8 kb bands.
3.1.10. Future Cloning ofpCSlO
pCS$ contains ail the elements necessary for gene targeting: 5’ portion of the
pPTPA plasmid, as well as boffi selection cassettes, and loxP and frt sites. However, the
3’ end of the PIPA sequence proper is 0.6 kb in length. This length may be insufficient
to guarantee efficient homologous recombination (see section 4.1.4.). Therefore,
although not absolutely necessary, one additional cloning step could be performed to
lengthen this sequence in the hopes of increasing recombination frequency. The pCS9
plasmid consists of the portion of PTPA that is immediately 3’ of the PTPA sequence of
pCS$. Jndeed, the NsiI located at position 11,087 ofpC$8 corresponds to the NsiI site of
pCS9, at position 2,237. These plasmids could be fused by ligating NsiI-linearized pCS9
with the 13.2 kb fragment generated by digestion of pC$8 with this same enzyme.
Ligation in the correct orientation will allow for the addition of 1.6 kb of the PIPA
sequence on the 3’ end ofthe PTPA-Neo-loxP sequence (Figure 14A).
Figure 13: Cloning of pCS8. A. Schematic representation of the clone. 3.
Agarose gel indicating the pCS$ clone was obtained (Lane 1, pCS$
undigested; Lane 2, pCS8 digested with ApaI; Lane 3, pCS$ digested with
EcoRI; Lane 4, pCS8 digested with NotI).
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The kanamycin resistance gene of pCS8 will be lost, but ail other sequences will be
intact. If many colonies are obtained, this restoring of kanamycin sensitivity wiii aÏlow
for negative selection to facilitate the screening process before performing restriction
digestion analysis on candidate clones.
Unfortunately, attempts to achieve this clone have failed so far. In fact, a number
of trials have produced ligated fragment and insert, yet only the incorrect orientation of
insertion was obtained.
When pCS1O is obtained, this plasmid will be linearized with XhoI (14B). The
resulting 13.3 kb fragment will contain the PTPA, loxP, frt, PGKNeo and PGKPuro
sequences, and will have lost the truncated ampicillin gene. This construct will be
purified and electroporated into ES celis for the eventual creation of PTPA-ioxP mice.
3.2 Transgenic mice
3.2.1. Screening for Transgenic Mice by Southern Blot
A DNA construct designed to drive Ptpa-EYfP expression in mice was prepared
by other members of our laboratories. The construct was microinjected in fertilized
oocytes and transferred to pseudo-pregnant females by the Centre de Recherche Guy
Bemier Animal Faciiity staff and 22 founder mice were carried to term (mice 1 - 22). 0f
these animals, a fraction were expected to have integrated the construct into their
genome. However, since the chromosomal integration of the construct occurred at a
postzygotic stage, these mice were expected to 5e mosaic, with transgene incorporation in
only a subset of cells. Therefore, transgene inheribitability would only be possible in
founder mice that carried this exogenous DNA in their germiine celis. In accordance
with Mendelian paftems of inheritance, a quarter of the progeny of these “ancestral” mice
would be expected to carry the transgene in ah cell types. Therefore, the founder
animais were crossed with fertile CD-1 mice of the opposite sex, and the resulting litter
was screened for transgene integration by southem blot.
Since animais were expected to carry the transgene in either all or none of their
cdl types, any tissue could have enabled us to perform the screen. We purified DNA
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with XhoI (B) for electroporation into ES celis.
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from mouse tails because this procedure provides the greatest yield possible without
requfring the animal to be sacrificed. Extracted DNA was screened by southem blotting,
using a radioactive-labelied copy ofthe ffihl-Jength PTPA-EYFP constmct as a probe.
Two major constraints throughout the screening process were the variable quality
and the relatively low quantity of DNA extracted from mouse tails. Consequently,
southem blots ofien revealed smearing of lanes, indicative of DNA degradation, and
hands of variable intensities. Yet, data amassed from several of these southem blots
suggested that three potentiai founder transgenic animals, mice 6, 7 and 16, had been
obtained (figure 15).
A number of mice were derived and screened from these three animals. The
quantity of genomic DNA extracted from mouse tau clippings was usually flot sufficient
to perform more than one southem blot for any given animal. Therefore, it was flot
possible to repiicate the procedure or to screen candidate transgenic mice more
rigorously. Had greater DNA yields been obtained, we wouid have repeated the southem
biot using probes consisting of variable portions of this constmct. This would have
allowed us to confirm that the transgene had been fully and stabÏy integrated in the
genome in candidate mice.
The southem blot data of transgenic animais from mouse une 6 (figure 1 5A)
highlights how more rigorous southem blotting could have further substantiated our
resuits. Transgenic offspring of a founder mouse are identical with respect to the locus of
transgene integration in the genome. Therefore, DNA extracted from animais derived
from mouse 6, digested and hybridized with the same enzyme and radioactive probe,
should have generated bands of the equal molecuiar weight on the southem blot.
However, as illustrated in figure 1 SA, two siblings from this mouse me appear to have
produced bands of different sizes. Several possibiiities can account for this discrepancy.
For example, it is possible that a meiotic recombination event occurred at a locus
immediately flanking the site of the transgene insertion in one of the animals, such that
the transgene was in greater proximity to a BamHI site (used to digest the genomic ONA)
in one mouse than in the other. In such an evenmaiity, the transgene would be localized
within BamHI fragments of different lengths, as detected in the southem blot.
Altematively, the different hands appearing on the southem blot may aiso be the resuit of
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rearrangement, such as a deletion of a portion of the transgene. It also possible that this
discrepancy is related to DNA degradation. Indeed, a “blotchy” smear appears below the
hand on lane 4 (Figure 15A), suggesting that the probe hybrdizied DNA at lower
molecular weights. This is consistent with hybridization of degraded DNA, which
typically generates a broad signal spanning wide range of molecular weights. Thus, had
mouse tau DNA extraction generated sufficient quantities of DNA, we would have
replicated this southem blot. Additional blots, in which genomic DNA would have been
digested with different enzymes and probed with different portions of the PTPA-EYFP
construct, would have heen performed, which would have allowed us to explore the
reason for the discrepancy in banding patterns in sihlings.
1234 1
:
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Figure 15: Southern blots for offspring of transgenic mice 6 (A, 3), 7 (C) and
16 (D). A., Lane 1, the DNA used to design the probe, as a positive control;
Lane 2 and 4; transgenic mice; Lane 3, wild-type mouse. B, Lane 1,
transgenic mouse. C, Lane 1, the DNA used to design the probe, as a positive
control; Lanes 2 and 3 transgenic mice. D. Lane 1, transgenic mouse; Lane
2, the DNA used to design the probe, as a positive control.
There is also some ambiguity in the southem blot for animais from mouse une 7
(Figure 15C). In addition to the relatively intense signal (lane 3), a faint hand of lower
molecular weight appears on the southem blot film. This hand is approximately the same
molecular weight as the unique hand observed in an adjacent lane (lane 4), in which was
loaded the DNA of non-transgenic offspring of mouse 7. This hand may represent weak,
non-specific hybridization of the radioactive probe to the genomic DNA. Altematively,
the “blotchy” appearance of the hand may be indicative that the perceived signal is an
A
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artefact ofthe biotting protocol rather than ifie resuit of probe hybridizing to mouse DNA.
Replicating the southem blot would have allowed us to determine the true nature of this
unexpected signal.
Thus, the resuits obtained from our southem blot screening were not aiways clear
and did flot demonstrate unequivocaliy that transgenic animais were obtained. Tbree
offspring of mouse 6 appeared to have integrated the transgene in ffiefr genome, but ail
three generated faint signais in the southem blot. However, since three potentially
positive mice were identified, of which two corresponded to the same molecular weight
(Figure 15A, lane 2 and Figure 153), we considered that it was worthwhile to further
investigate whether or flot these mice were tnily transgenic and actuaiiy expressed Ptpa
EYFP. Only two offspring from mouse 7 appeared to carry the transgene. Yet, the
strong intensity of the signal for both these animais prompted to us to explore the
possibility that animais from this mouse me expressed Ptpa-EYFP. Mouse une 16
provided less compeliing evidence as only one offspring reveaied a positive signai in the
southem biot. Stili, given that our laboratories had decided to pursue the investigation of
two candidate mouse families, it was decided that this thfrd une, aithough uncertain,
wouid be also explored. Jndeed, we hypoffiesized that given the wide range of pathways
in which Ptpa is invoived, it was possible for the transgene expression to have a
deieterious or lethai effect on the animais. In such a case, fewer transgenic mice would
develop to adulthood than would normai mice, accounting for the iack of transgene
detection in me 16. Thus, our overali strategy consisted of exploring two mouse mes
that had produced positive resuits by southem blot in two or more offspring of founder
animais, and one une that was perhaps more tenuous, but that was potentially of interest
given the function of Ptpa.
These candidate transgenic animais were crossed with fertiie CD-1 mice in order
to expand these into large mouse unes. Birth and deveiopment pattems appeared normai
for ail three mes. This is particularly noteworthy for mouse me 16; had the transgene
expression caused a serious and deleterious effect, either it would have been expected
that fewer pups be bom, or that animais have a greater propensity to disease. These
normal pattems strongiy suggested that the hypothesized adverse effects of Ptpa-EYPFP
expression couid not account for the iack oftransgene detection in mouse-iine 16.
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3.2.2. Assessing Transgene Expression by Western Bloffing
The southern blotting for transgene integration into genomic DNA did flot permit
us to fuily characterize candidate transgenic mice because of initial difficulties in
optimizing DNA extraction techniques and insufficient DNA yields. Conversely, large
quantities of protein can be extracted from virtuaily any tissue. In addition, our
laboratories possessed effective and specific antibodies for Ptpa and EYPF. Therefore,
our laboratories sought to examine the possibility of transgene expression in candidate
animais by western blot.
Protein was extracted from various tissues, including the liver, kidneys, lungs,
heart, intestine, spleen and skin from the animals in which a signal was detected by
southem blotting as well as offspring derived from matings with CD-1 mice. Western
blots were performed with these tissues with both anti-GFP and anti-Ptpa antibodies.
GFP variants are 27kDa proteins. Therefore, fused to Ptpa (37kDa), the expression ofthe
transgene was expected to have a moiecular weight of 64 kDa.
The anti-Ptpa antibody detected several non-specific bands. $everal peptides
were detected by this antibody, as is generaily the case for polyclonal antibodies. Yet,
this anti-Ptpa effectively detected the 37 kDa endogenous Ptpa protein. However, in
comparing adjacent lanes for wild-type controi and candidate transgenic protein extracts,
the western blot did not reveal transgeaic-specific bands of 64 kDa (Figure 1 6A) or any
other weight.
The monoclonal anti-GFP antibody revealed one strong signal of approximately
40 kDa as well as a few faint bands. This strong signal probably does flot represent Ptpa
protein. The secondary antibody for the GFP blot is a mouse anti-IgG. This hand likely
represents a component of a mouse protein recognized by this anti-IgG.
Figure 16 illustrates western blots performed for an animal from mouse me 6 for
which appeared positive by southem biot. $imilar patterns were observed for animais of
ail other mouse unes. Thus, molecuiar methods indicated that the candidate transgenic
mice did not express the transgene in the specific tissues screened.
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Figure 16: Western blotting for detection of transgene expression using (A) anti
PTPA and (B) anti-GFP antibodies (wt, wild-type; t, transgenic).
3.2.3. Macroscopic Observation of EYFP to Assess Iransgene
Expression
Having failed to identify animais expressing Ptpa-EYFP by western blot, we
hypothesized that perhaps only very specïfic tissues expressed the transgene. In addition,
we also hypothesized that In order to rapidly test for gene expression in many animais
and a greater number of organs, we sought to screen for EYFP fluorescence
macroscopically. Therefore, a large number of wiid-type and potentially transgenic
animais from families 6, 7 and 17 were sacrificed, dissected and observed under the
Clare Chemical Dark Reader Spot Lamp using viewing goggies. Unfortunately, one of
the short-comings of the Spot Lamp is that it does flot aiiow for photographs of animais
to be taken.
Consistent with the western blot resuits, no fluorescence was detected on the
hairless surfaces of mice (such as feet or ears), or in hairless pups. In anticipation of a
mosaic pattem of expression of the transgene, animais were sacrificed and dissected.
Vïewing approximately 15 individuals from the three mouse unes, including the
candidate mice identified by southem biotting did flot reveai any fluorescent tissue type
in any animai. The only exception was an individual from the transgenic family 16,
whose seminal vesicle seemed to fluoresce. However, this was flot observed in any other
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animais, including siblings of the mouse in question. In addition, since this individual
had been sacrificed, we were flot able to exploit this possibility further. Consequently, it
seems that the transgenic mice generated did flot express the transgene to any significant
extent.
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4. Discussion
Recent advances in molecular biology techniques enabling scientists to generate
transgenic and knockout mice have allowed for unprecedented investigation of general
mammalian biology and pathology, as well as targeted genetic studies. Ihe Cre/loxP
system for creating conditional knockout mice and the use of Green Fluorescent Proteins
as tags and fusion proteins have become powerful means of achieving a high degree of
genomic tailoring. Although these methods are technically difficuit to develop, our
laboratories have sought to exploit them to further our understanding of the role of PIPA
in the response to oxidative stress.
Overali, our goals of generating both conditional knockout and transgenic mice
for the PIPA gene have flot yet been achieved. Several constructs were created in
preparation for a targeting vector to allow the creation of the conditional knockout mice.
Only one fmal cloning step, conceived to increase the length of homology on the 3’ arm
of the PIPA gene, is required before the plasmid can be electroporated in embryonic
stem cells. Furthermore, it appears that the mice designed to express EYFP-ffised Ptpa
did flot express the transgene. Ihis section addresses a number of issues and details that
were considered throughout the various stages of theses projects. In addition, a number of
recommendations are made that may maximize the chances of obtaining fluorescent-Ptpa
transgenic mice in the future.
4.1. The Creation of Condïtional PTPA Knockout Mice Targeting
Vector
The Cre/loxP system is an extremely useful tool in mouse studies because it
allows the experimenter to control the location and time of the knockout event at any
stage of mouse development. However, this method requires that a number of
modifications be made to the mouse genome: two loxP sites must be engineered flanldng
the exons that are to be deleted by the Cre recombinase, and two selection markers (one
within the targeted sequence and one on either the 3’ or 5’ end of the vector) are to be
inserted. Ihis makes the design of the targeting vector complex and challenging. In
addition, several precautions must be taken to maximize homologous recombination
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efficiency and to minimize the effects that the modified DNA may have on the targeted
gene and its protein product. An important limiting factor is the availability of restriction
sites for cloning after every cloning step; as each construct is being “assembled,” fewer
unique sites are present, making subsequent cloning steps more difficuit to perform.
4.1.1. Targeting Vector Must 5e Isogenic with Mouse ES Strain
Various ES celi unes are available for the generation of knockout mice. The
genomic sequence of PTPA was obtained from the mouse strain 129. This background is
significant because it has been reported that differences in genetic background between
the ES ceil une and the DNA of the targeting vector could decrease the frequency of
homologous recombination (te Riele et al., 1992). Therefore, ES ceils derived from the
129 mouse strain will eventually be used for gene targeting. Tndeed, several studies have
shown that ifiis is an efficient strain for the creation of targeted deletions in mice
(Dobrovolsky et aï., 1996; Ware et al., 2003).
4.1.2. Utilizing Selection Markers
Integration of a positive selection marker within the targeting vector is needed to
select for ES ceils that have incorporated the vector within their genome. However,
while this process enriches for ceils that have incorporated the targeting vector within
thefr genome, it does flot distinguish between random and homologous recombination
integration. b eliminate ceils having incorporated the construct at non-homologous
sites, Mansour et al. (198$) developed the “positive/negative selection” strategy. This
approach cails for the construction of a targeting vector containing two antibiotic
resistance genes: one for positive selection, to be engineered within the genomic DNA
sequence of the vector, and another for negative selection, to be added to either extremity
of the constmct.
The rationale for this design is that randomly integrated exogenous DNA is
incorporated in its entirety, whereas the process of homologous recombination eliminates
non-homologous ends. Therefore, ES celis that have undergone HR will have integrated
only the positive selection marker. Thus, two rounds of selections, one positive and one
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negative, are needed to enrich for the correct clones; candidate celis exhibit resistance to
the former and retain sensitivity to the latter.
In ffiis study, the neomycin gene conferring resistance to G418 was integrated
within the PIPA sequence for positive selection, whereas a puromycin resistance gene
was cloned on the 3’ extremity of the targeting vector. The expression of both resistance
genes is assured by the PGK promoter, which is routinely used in ES ceils for targeted
deletion applications (Hannan et aÏ., 1993).
4.1.3. Use of the Frt/Flp System
Ihe purpose of generating conditional knockout mice is to produce wild-type
animais who have a spatially andlor temporally-limited sequence deletion. However, the
very presence of a positive selection marker integrated within the targeted genomic DNA
may disrupt the normal expression of this gene (fiering et al., 1995), regardless of the
location and timing of Cre expression. To prevent this, we have sought to use the strategy
developed by Fiering et al. (1995) and Zhao et al. (2001), which allows the removal of
the positive selection marker using the frtfFlp system. Briefly, the targeting vector is
designed such that this gene is flanked by frt sites. ES celi unes established as having
integrated the targeting vector via HR are transfected with an cflp (enhanced Flp)
recombinase-expressing vector. This mediates recombination between the frt sites,
effectively deleting the selection marker sequence from the genomic DNA. Having lost
the resistance gene, the resultant ES celis would be genetically identical to wild-type ES
celis with the exception of the two short loxP sites of 34 base pairs each, bringing the
genomic modifications to a minimum. Many eFlp-expressing vectors are available
commercially. For example, pCAGGS-FLPe, supplied by Gene Bridges (Dresden,
Germany, http://www.genebridges.com), has been shown to remove sequences flanked
by frt sites in ES celis effectively (Schafi et al., 2001).
In the case of the PIPA targeting construct, we have used an frt-flanked
neomycin gene from the pK-1 1 vector (Meyers et al., 199$). The loxP sites are located
5’ and 3’ of the frt-neomycin sequence. Iherefore, the loxP sites would be left intact
upon Flp-mediated recombination. Ihose ES ceils that have lost the marker can be
selected by southem blot. Altematively, celis having lost resistance to G41 $ would also
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indicate the loss of the neomycin gene mediated by flp. following this step, the usual
protocol for transfen-ing ES celis to a pseudo-pregnant female can be followed.
Although the removal of the PGKNeo cassette is not absolutely required, this
additional step provides two advantages. First, it minimizes the degree of modification
incurred by the genomic DNA, preventing the potentially disruptive effect of maintaining
the selection marker within the mouse genome. In addition, upon removal of the Neo
gene, ES ceils can be targeted again by the same construct, producing ceils that contain
the loxP sites on both PTPA alleles. These conditional knockout unes could be useful for
investigating the function ofPTPA in embryonic stem celis.
4.1.4. Length of the Targeting Construct
Homologous recombination between exogenous and genomic DNA is a process
that occurs spontaneousÏy in ceils at low frequency. More often, rather than undergoing
HR and replacing the endogenous sequence with targeting vector, ceils will incorporate
the vector randomly into their genome. Although the positive/negative selection process
enriches for ceils that have undergone homologous recombination, it does flot increase
the frequency of HRper se.
One factor that may increase the homologous recombination frequency in ES celis
is the length of the homologous sequence. $everal reports have indicated that the lower
limit ofhomology is rather low (Hasty et aï., 1991; Deng and Capecchi, 1992; Thomas et
al., 1992). Hasty et al. (1991) reported that as littie as 472 bp homology was sufficient
for recombination to occur. $ubsequently, it was found that longer lengths of homology
could increase the frequency of HR significantly (Deng and Capecchi, 1992). A more
recent study (Lu et al., 2003), indicated that the relationship between the length of
targeting arms and recombination efficiency is more complex. In this study, 8, 16, 24 and
110 kb homology length between the targeting vector and genomic DNA were shown to
undergo HR at similar frequencies. The authors hypothesized that recombination
frequency depend on several other factors, “such as the targeted locus itself, vector
design, and the status of cellular HR machinery.”
The completed PTPA-loxP targeting vector will have 5’ and 3’ arms of homology
of 4.1 and 1.8 kb, respectively. According to the HR frequency rates established by Deng
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and Capecchi (1992), this should allow for efficient homologous recombination.
However, there is no way of anticipating or circumventing the other variables that may
affect this efficiency. It may be necessary to “troubleshoot” modifications to the
constructif HR frequencies are too low.
4.1.5. Incorporation of loxP Sites
Ihe loxP sites must be engineered so that they flank a sequence that is deemed
essential for gene function. This sequence will be removed from the mouse genome upon
Cre-mediated recombination, transiating into a non-functional protein. We have opted to
incorporate the loxP sites flanking exons 6 and 7 of the PIPA gene. Ihese two exons
correspond to 77 amino acids (approximately 25% of the full length protein). More
importantly, they include sequences that are highly conserved in ail organisms. Exon 6 is
the DNA sequence coding for a portion of the first conserved region, whereas exon 7
corresponds to the entire sequence ofthe second conserved region (Figure 2, in bold). In
addition, a point mutation within this second region in which an aspartic acid residue is
substituted with a glycine residue (D213G), completely aboiishes yeast Rrdl flmction,
causing ceils to be exhibit a sensitivity to 4-NQO simiiar to Rrdl-deficient ceils
(unpublished data). Iogether, these features indicated that this sequence was a good
candidate for targeted deletion of PIPA.
4.1.6. Future Directions: Generating Conditional Knockout PTPA Mice
When the targeting construct is finalized, it wiil be linearized with XhoI (Figure
14). The targeting vector will then be electroporated into ES ceils. Celis having
integrated the construct within thefr genome will be selected using G41 8. The puromycin
negative selection will eliminate celis that did flot go through homologous recombination.
Candidate G41 8-resistant, puromycin-sensitive ceil unes will be screened by southem
blot. it is important to note that only one PIPA allele is expected to undergo homologous
recombination.
Once candidate ES ceils unes are confirmed, they can be transfected with eFlp
expressing plasmid, removing the neomycin resistance gene from the genomic DNA.
Ceils will then be transferred to the inner ceil mass of a blastocyst, to be subsequently
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implanted in a pseudo-pregnant female. $ince the inner ce!! mass will consist of ES ce!!s
of which only a fraction are carrying the genetic modification, the resu!tant pups will be
chimeras, the loxP sites present merely in a subset of their tissues. Other tissue types wi!!
be completely wild-type.
These chimeras will be crossed with wild-type animais and their offspring will be
screened by southern biot. This wiIi a!low the identification of the founder mice that
carry the loxP sites in their germ!ine. Positive offspring wi!1 then be mated with the
transgenic mice capab!e of expressing the Cre recombinase so that a fraction of the
resu!ting mice wi!! carry the loxP sites on one PTPA allele as we!! as the recombinase
gene. Finally, two such siblings (carrying both the loxP sites on one PTPA allele and the
recombinase gene) wifl be crossed to obtain mice with the loxP sites on both alleles, as
well as the ability to express Cre (Figure 17).
Gene targeting and
remova of Neo
. -
gene by FIp
Transfer of ES celis to
pseudo-pregnant
temale
Crossing of pups with /k 6
wiId-type mouse to t)
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Gte recombinase.
Crossing of
_c-jjj-ci_ 4)
letgzYote PIPA-
-ê-J X S)
Identification of
homozygote PTPA
loxP/Cre mice.
Figure 17: Generating PTPA-loxP mice. Arrows indicate loxP sites. Both
alleles of the PIPA gene are shown.
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A variety of mice expressing Cre under the control of inducible or tissue-specific
promoters has been developed. These present interesting options for targeting PIPA
deletion once PTPA-loxP mice have been generated. For example, the Tyr::Cre mouse
une expresses the recombinase under the control ofthe tyrosinase gene promoter (Delmas
et al., 2003). This tightly regulated promoter drives gene expression in melanoblasts
from embryonic day 11.5. Thus, if crossed to PTPA-loxP mice, only ceils deriving from
this precursor ceil type will become PIPA-deficient. The celi lineage includes
melanocytes, which is of particular interest given the reiationship between UVA-induced
oxidative damage and melanoma.
Altemativeiy, the CreR (T2) is a mouse une that ubiquitously expresses the Cre
recombinase upon induction by tamoxifen and certain tamoxifen anaiogs. This mouse
une expresses the recombinase fused to a modified oestrogen binding domain; oniy upon
administration of these dmgs does the protein become active. In addition, in the absence
of tamoxifenltamoxifen-analog activation, this mouse une exhibits a very low level of
basal Cre activity. Finally, low doses of the dmgs can efficiently activate the
recombinase. This is a considerabie advantage over other inducibie Cre mice, in which
the recombinase can oniy 5e activated when animais are treated with higher doses of
drugs, ofien causing side effects (feu et aÏ., 1997).
Many other mouse fines expressing the Cre recombinase under the control of
inducibie or tissue specific promoters are commercialiy available. The Jackson
Laboratory’s “Cre deleter” mouse strains and Artemis Pharmaceuticals’ Cre
Recombinase Zoo provide a wide range of tissue- and time-specific Cre-expressing mice.
The PTPA-JoxP mice could be crossed with one or several of these Cre animais, maldng
the conditionai knockouts very versatile, allowing the study of PIPA function in different
tissues andlor at different stages of deveiopment.
4.2. The Creation of Mice Overexpressing PTPA and Fused to EYFP
In addition to generating PTPA knockout mice, our laboratories were interested in
observing the effect of Ptpa protein overexpression on the response to oxidative stress in
mice. Generally, transgenic mice are produced more rapidly than knockout mice and are
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less prone to embryonic lethality. Therefore, we attempted to generate mice that would
express the transgene, tagged to a GFP, ubiquitously, rather than limiting its expression to
specific tissues. GfPs are powerful tools for microscopic (intracellular localization ofthe
fusion protein, FACS analysis, etc.) and macroscopic (animal typing and screening)
applications. Further, our laboratories did flot initially have a reliable anti-Ptpa antibody.
Producing Ptpa fused to a GFP was considered advantageous because the tag could be
detected by a commercially available anti-GFP antibody.
4.2.1. Choice of Green fluorescent Protein Variant
Since Green Fluorescent Proteins were first discovered and characterized in 1978,
applications have evolved tremendously. Mutagenesis experiments have generated a
variety of GFPs, characterized by different spectral features and quantum yields. The
enhanced GFPs (eGFPs), such as EGFP, EYFP and ECFP, have distinct and only
partially overlapping emission and excitation spectra, and different quantum yields.
These have been used successfiully in celi unes as well as in whole animais (Zhu et al.
1999; Frank et al., 2003).
We have opted to generate mice expressing the EYFP-fused Ptpa protein. Used as
a tag, EYFP, like other GFPs, can be readily visualized macroscopically in mouse tissues.
Thus, once transgene expression is confirmed by western blotting, subsequent screening
of transgenic mice couid be performed through the empiricai observation of fluorescence.
In the event that transgene expression is flot ubiquitous, aduit mouse dissections could be
performed to screen macroscopically for expression within specific tissue. In addition to
utilizing the rapid, simple and non-invasive method of screening animais described
above, EYFP could be detected in primary celi lines derived from transgenic mice
Therefore, microscopic observations would allow us to localize and quantify the tagged
Ptpa in ceils.
The most appealing property of the EYFP variant is its high quantum yield. Like
other GFPs, EYFP requires excitation by specific wavelengths to emit its fluorescence.
This variant’s quantum yield is 0.61, emitting a greater number of photons per excitation
photon than other GFPs (Ormo et al., 1996). Consequently, we judged that the use of this
variant would best guarantee a strong and clearly visible signal.
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4.2.2. Detection of Transgene Expression
Upon estabiishing candidate mouse unes, DNA of individuai mice from different
families was extracted from tau ciippings and screened by southem blofting. Having
found severai individuais appearing to carry the transgene, we sought to identifj animais
in which Ptpa-EYfP was expressed. Initially, we dissected several individuals of
different mouse unes, isoiated a number of tissues from which protein was extracted and
performed western biots. Initiaiiy, we used an anti-GFP antibody that can detect GFP
variants including EYFP. No detectable signai for Ptpa-EYFP was obtained. Western
blots were repeated when our laboratories subsequently obtained an anti-Ptpa antibody.
Aithough, this antibody detected the endogenous mouse Ptpa very effectiveiy, it did flot
reveal the expression of the transgene. Upon dissecting many animais from three
families and repeating the procedure several times, it was conciuded ffiat no transgene
expression could be detected by western blot.
Following our use of moiecular techniques to detect Ptpa-EYFP expression, we
obtained equipment that would permit the macroscopic detection of fluorescence. A
number of costly apparatuses are avaiiable commerciaiiy for such applications (Budapest,
Hungary, www.bis-ltd.com). Our iaboratory used a more cost-effective system, the Ciare
Chemical Spot Lamp Kit and observation goggies (Dolores, USA,
www.clarechernical.com). This kit aiiows macroscopic visualization of even low leveis
of fluorescence. Its major limitation is that it is not possible to combine it wïth
photographic equipment that would aiiow pictures ofthe fluorescence to be taken.
The light source of the Spot Lamp consists of a bright light with an excitation
filter limiting the light emission to wavelengths between 400 nm and 520 nm. The
goggies act as an emission filter, enabling the viewer to see waveiengths above 540 nm.
Although these do not correspond to the emission and excitation maxima of EYFP, the
ranges of waveiengths closeiy match the spectmm of this GFP variant (Ormo M et al.,
1996).
Initiaiiy, only hairiess pups were screened for expression of EYFP because the
emitted fluorescence is only readiiy visible in hairiess tissue. These macroscopic
observations did not reveai fluorescence. It was hypothesized that oniy a subset of tissues
expresses the Ptpa-EYFP fusion. Therefore, several mice from different mouse unes
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were sacrificed, dissected, and their inner organs observed with the Spot Lamp and
observation goggies. Again, no EYFP expression was detected, with the exception of one
animal whose seminal vesicle appeared to emit fluorescence.
In sum, despite the confirmation that proper integration of the construct into the
mouse genome in different mouse unes, none of these was found to overexpress Ptpa or
to express EYFP, as ascertained by western blotting using antibodies for mouse Ptpa and
GFP. In addition, except for one animal, macroscopic observations did flot reveal
fluorescence in any tissue.
4.2.3. Possible Reasons for the Absence of Transgene Expression
A number ofreasons may account for the absence oftransgene expression. It was
initially hypothesized that transgene expression may have a negative effect on the heaith
of embryos or pups, preventing us from detecting transgenic adults by southem blot.
Indeed, this hypothesis was later substantiated in our laboratories (see Section 4.3.). If
this were the case, female mice wouid have given birth to fewer pups per pregnancy, a
fraction of the embryos having died because of the transgene expression. Oui
observation that mice had normal pregnancy and birthing paffems excluded this
possibility.
This lack of Ptpa-EYPf expression is more likely due to the choice of the
promoter driving the transgene expression. The PTPA-EYFP construct was designed by
incorporating a copy of mouse PTPA cDNA into the pEYFP-N1 plasmid (Ciontech),
which contains a CMV promoter. We relied on the CMV promoter to drive the
constitutive expression of the transgene. However, this promoter has been associated
with suboptimal pattems of protein expression in animais. One study demonstrated that
a transgene is driven in different tissues to variabie extents in transgenic animais (Baskar
et al., 1996). This finding was confirmed in a more recent study involving CMV
promoter-driven GFP expression in mice. Villuendas et al. (2001) reported that
generally, this promoter does flot drive the expression of significant levels of green
fluorescent protein in mice tissues, the only exception being male reproductive organs.
This is partially consistent with oui observation of EYFP in the seminal vesicle in one
animal.
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Indeed, upon surveying the literature, it appears that the majority of researchers
who successfiuly generated GfP-expressing mice did so utilizing the chicken beta-actin
promoter (Okabe et al., 1997; Sato et al., 2001; frank et aÏ., 2003).
4.2.4. Proposed Modifications for Future Transgenic PTPA-GFP
Studies
In the future, a number of modifications shouid be made to increase the chance of
obtaining mice with a strong transgene expression and to maximize fluorescence
emission. Primarily, the chicken beta-actin promoter should be used, as in other studies
reporting strong fluorescence expression in mice. Additionaliy, the EYFP variant shouid
be repiaced with EGFP. EGFP has a broader emission and excitation spectra than EYFP.
The former can consequently be visuaiized macroscopicaiiy with a standard hand heid
UV lamp or the Clare Chemical Spot Lamp, without requfring the use of stringent filters
that allow only a narrow range of wavelengths to pass through. In addition, since EGFP
has a broad emissionlexcitation spectrurn, the fluorescence in celis isoiated from mice can
be visualized microscopicaliy using conventional GFP filters and analyzed by FACS
using standard parameters. In contrast, EYfP’s narrower excitationlemission spectra
render microscopic fluorescence visualization and FACS analysis inaccurate unless
specific filter sets are acquired and standard FACS parameters modified.
4.3. Future Directions for PIPA Condïtional Knockout and Transgenic
Mice
Using animais to study the role of PTPA in the celiular response to oxidative
stress is a promising endeavour. In the short to medium term, much effort will be
required to generate mice that wili carry and express the appropriate genomic
modifications. This is, in and of itself, very labour intensive. In addition, altering Ptpa
expression may have a deletrious or lethal effect on the experimental animais, making it
difficuit to generate the desired lineages.
Indeed, it has been demonstrated that both the suppression and overexpression of
Ptpa cause ceil deakh. Feilner et aÏ. (2003) reported that PTPA-RNAi-transfected HeLa
ceils underwent apoptosis. Recent unpubiished data obtained in our laboratories provides
evidence that excess amounts of the protein is equally damaging to the ceil; a sharp
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decline in survival rates was observed in HCT 116 celis transfected with a plasmid
driving the expression ofPtpa-EYFP, 24 and 4$ hours post-transfection (see Appendix).
The ultimate goal for developing transgenic and knockout PTPA mice is to gain
insight into PTPA fiinction. Preliminary experiments should consist of treating the
genetically modified mice with different doses of ROS-inducing agents by feeding them
with drugs ifiat are known to produce oxidative stress or by exposing them to UVA.
Given the potentially diverse roles of PTPA, it should be expected that a number of
phenotypes be observed. As such, it is difficuit to outiine a detailed experimental plan.
Rather, experiments using these mice will have to be continuously refmed and adjusted
with emerging phenotypes.
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5. Conclusion
The study of oxidative stress is of great relevance to several contemporary health
issues. A better appreciation of the genetic factors underlying the cellular response to
ROS will help refme our understanding of the biology of reactive oxygen species and
their role in disease, eventually enabling the development of effective preventative andlor
curative measures.
Ihe yeast homologue of the mammalian PIPA gene has been shown to play a
role in the response to oxidative stress, particularly in maintaining DNA integrity
upon ROS insuit. Although the no clear gene function emerges from the literature,
several unes of evidence suggest that it may also be involved in a variety of other
important pathways. Evidence supports a role for this gene in mechanisms related to
carcinogenesis. Therefore, our laboratories undertook the task of exploring the roie of
PIPA in the response to oxidative stress in greater detail, focusing on possible
implications for the study carcinogenesis.
The manipulation of the mouse genome to alter gene expression is an extremely
powerful, almost indispensable, tool for the study of gene flmction and pathology, at the
level of the entire organism. Indeed, traditional knockout and transgenic mice have
become commonplace. Ihese methods are continuously being refined to help achieve a
greater “tailoring” of the mouse genome. The Cre/loxP system and the Green Fluorescent
Protein allow the generation of powerful, practical and versatile genetically modified
mice.
We have sought to exploit these technologies to determine the fimction of the
PIPA gene in mammals. A targeting vector containing the various elements required for
the generation of conditional knockout mouse was prepared. One more cloning step is
requfred before the constmct could 5e electroporated to ES ceils. In addition, transgenic
mice, anticipated to express Ptpa protein fused to a Green Fluorescent Protein-derivative,
were produced. Unfortunately, expression of the transgene was not detected. A number
of modifications can be made to the construct that was utilized to generate these mice,
which will almost certainly yield resuits that are more fruitfiil in the future. Once the
7$
mice are finalized, experiments will be performed that will, hopefully, help elucidate the
PTPA’s function in the response to oxidative stress and related pathologies.
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CMV-PTPA-EYFP-transfected HCT 116 CMV-EYFP transfected ceils untransfected ceils
24h 48h 48h 48h
total ceils 4.08 X106 4.33 X10 9.34 X106 9.25 X106
count
dead ceils 0.98 X106 1.63 X106 0.66 X106 0.15 X106
living ceils 3.1 X106 2.7 X106 8.68 X106 9.1 XJOb
% survival 75.98 62.35 92.86 98.37
Figure 18: Ptpa-EYFP expression decreases survival rates of HCT 116 ceils. A,
Western blotting for detection of Ptpa-EYFP expression using an anti-GFP
antibody. B, Survival rate of CMV-PTPA-EYFP-transfected celis.
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6. Appendix
Our laboratories have generated a celi-line in which Ptpa-EYFP is expressed. HCT 116
celis, derived from a primary colon carcinoma of an aduit man (Brattain et al. 1982),
were transfected with the CMV-PTPA-EYFP construct, identical to the one microinjected
into fertilized oocytes for producing transgenic mice. Ptpa-EYFP expression was
determined by western blot analysis using an anti-GFP antibody (Figure 18a).
A
- mil tnPTPA
B
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A clear signal immediately above the 62kDa marker hand in lanes representing protein
extracted from celi 12, 24 and 48 hours post-transfection, indicates that the Ptpa-EYFP
construct is expressed.
Concomittant with Ptpa-EYFP expression, a marked decrease in celi survival is
observed. In contrast, a culture of CMV-EYFP-transfected HCT 116 ceils bas a survival
rate similar to that of untransfected ceils, suggesting that the overexpression of Ptpa is the
major cause ofthe decline in survival rates.
The figure and data were compiled by Sonish Azam and Xiaoming Yang.
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